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DETECTION AND CHARACTERIZATION OF PYROMARKERS OF SMOKED 
DRUGS OF ABUSE 
 
Rona Kiyomi Nishikawa 
 
 
 Smoking or inhalation has increased in popularity as the choice route of 
administration of drugs of abuse amongst drug abusers.  Combustion products associated 
with the smoking event (pyromarkers) of these smoked drugs of abuse can be useful in post 
mortem toxicological analysis both for investigative and public health applications.  A 
method using analytical pyrolysis was developed to simulate the smoking process used for 
illicit drugs, which is significantly different than methods used for studies of conventional 
tobacco smoking, This method was used to identify possible markers associated smoked 
fentanyl and mixes of heroin and fentanyl.  Thermocouple temperature probes were used to 
analyze the temperatures obtained through smoking the fentanyl transdermal patches (FTPs) 
in means of the “chasing the dragon” technique.  These temperatures were then applied to the 
pyrolysis gas chromatography (Py-GC/MS) to mimic these smoking conditions to determine 
pyromarkers that were produced.  The presence of a trap on the pyrolysis unit allowed for 
aerobic conditions by exposing the pyromarkers to air.  A second advantage of trapping is 
preconcentration of pyromarkers.  The method enhanced the recovery and afforded a positive 
identification of the pyromarkers.  The methods and models developed here can be extended 
to any smoked drug, including drugs of current concern such as cannabinomimetics and 
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Chapter 1: Introduction 
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1.1.0 Development of Research 
 
Smoking or inhalation of drugs has become a popular route of administration amongst 
drug abusers.  The physiological goal drug abusers see when smoking commonly smoked 
drugs of abuse, as listed in Table 1-1, is to obtain the sought after drug induced sensations, 
which can range from euphoric, to sexual, and analgesic effects.1-3   Because smoked drugs 
are rapidly introduced into the bloodstream through absorption in the lungs, there is an 
increased risk of overdose and the potential production of toxic pyrolytic products that are 
not associated with other modes of administration.  Thermal degradation of the parent drugs 
or other impurities can lead to the potential production of toxic pyrolytic products and can 
increase the risk of overdose.  The drug pathway can also be heavily influenced by the 
anatomy and physiology of the lungs.   
The term pyromarkers used here is any substance that is an indicator of a compound 
that undergoes pyrolysis.  Pyrolysis is simply the breaking apart of chemical bonds by the use 
of thermal energy only, whereas combustion involve the exposure to oxygen to allow 
oxidation to take place.4,5  Analytical pyrolysis is the technique of studying molecules either 
by observing their behavior during pyrolysis or by studying the resulting molecular 
fragments that can infer  much about the nature and identity of the original larger molecule.5  
Detecting pyromarkers of smoked illicit drugs in human biological fluids can be used as a 
means of identifying individuals who are chronic users and abusers.  The confirmatory 
methods that provide this information are widely used as tools for investigative purposes.  
The identification of the chemical composition of smoked drugs of abuse, in conjunction 
with enzymatic studies, can be used to identify potential unique pyromarkers in human 
biological matrices of those exposed.  In addition, identification of these pyromarkers would 
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aid in the understanding of pharmacological and toxicological effects associated with 
exposure as a result of smoking drugs of abuse.  In many instances, the drug abusers 
unknowingly expose themselves to something more toxic than the drug itself in which case 
the cause of death is not what might otherwise be assumed.  
Although an intravenous injection produces the fastest rate of onset of toxic effects, 
smoking or inhalation is often preferred by users due to the fear of contracting AIDs, 
hepatitis, or other blood-borne infectious diseases from needle sharing.6  Other problems of 
infection include abscesses, collapsed veins, necrosis, sepsis, and endocarditis.7  Needle 
marks, such as bruising and scar tissue, can be avoided if smoking is used instead of 
injection.  Smoking is not perceived to be as culturally deviant and drugs abusers associate 
intravenous injections with “hardcore users” due to extensive tobacco and marijuana 
smoking in many areas.8  An increase in the availability of some drugs of abuse has led to a 
decline in price and subsequent shift in the trend towards smoking drugs.  Also, the 
willingness of many individuals to smoke drugs can play a major role in the emergence of 
drugs, such as the crack cocaine upsurge in the 1980s.8  
The process of smoking may increase the risk of other hazardous effects caused by 
pyromarkers that are not associated with other modes of administration.  Inhalation as the 
route of administration of a drug incorporates the anatomy and physiology of the lung that 
heavily influences the drug action.  This is partly due to the large surface area of the lungs 
and extensive capillary network in close association with the alveoli with particles less than 1 
μm in diameter.9,10  First, there is the absorption of the inhaled drug.  There is an increased 
bioavailability when the fentanyl is inhaled, given that first-pass metabolism in the liver does 
not occur.  The fast absorption from nasal mucosa and extensive lung capillaries results in an 
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immediate elevation of arterial blood drug concentration.6  Many drugs of abuse, particularly 
non-ionized lipophilic, drugs move rapidly from the alveolar spaces into the systemic 
circulation.8   The total distance between this alveolar space and plasma is estimated to be 
about 0.5 and 2.5 μm of cellular layers of the respiratory membrane.9,11,12  In addition, 
although absorption may take place over the entire respiratory tract, the largest surface area is 
presented by the alveolar epithelium with an estimated area of an adult is 35 m2 during 
expiration and 100 m2 in maximal inspiration.9,13,14  There is a relatively small total volume 
of blood in lungs (60-140 mL) that is spread over the large surface area,  which results in a 
thin film of blood with a thickness of 8 μm that is similar to the diameter of pulmonary 
capillaries.9,12  This optimizes the process of absorption from the alveolar space into the 
plasma.  When drugs are inhaled, they are delivered and distributed to target organs rapidly 
due to the high pulmonary capillary blood flow.  Rapid delivery of drugs to the brain may 
also lead to other adverse effects, such as pulmonary disease or deleterious cardiovascular 
consequences.6  The high concentration of drug in the arterial blood can produce an intense 
psychoactive effect which can be qualitatively different from the drug’s steady state effect.8  
Other routes of administration do not typically experience the desired “rush” feeling felt by 
the abuser while smoking.  
Secondly, uptake by the lungs allows the retention and short-term accumulation of the 
drug being smoked.  This is due to the extensive involvement of extra- and/or intra-cellular 
binding to various proteins, receptors, and in some cases energy-dependent active transport.8 
The lung becomes a reservoir for slow and persistent release of drug into the circulation and 
at high concentrations could result in local toxicity in the lungs. 
 5 
Lastly, the lung is able to metabolize some drugs and endogenous chemicals by  
similar pathways as the liver.8  The ultimate goal of lung cells is to facilitate the elimination 
of lipophilic substances that would otherwise accumulate in cellular lipids.15  The 
concentration of drugs brought into contact with drug-metabolizing enzymes in the lungs is 
much greater than the liver due to the higher blood flow, even though the lung tissues have 
lower concentrations of drug-metabolizing enzymes than the liver.8  Therefore, metabolism 
by the lung can contribute substantially to total drug metabolism.  Cytochrome P450 activity 
is primarily in nonciliated bronchial epithelial and Type 2 alveolar cells, which are most 
susceptible to injury as a result of metabolism of certain drugs and chemicals to reactive 
metabolites.8  
In addition, the thermal degradation of the parent drug or other impurities can lead to 
the inhalation of toxic pyromarkers.  An example of this, reported in the 1980s, is heroin 
leucoencephalopathy, a life-threatening condition of the brain that has occurred in individuals 
after smoking heroin.16,17 Heroin leucoencephalopathy is not associated with intravenous 
injection administration and no impurities present in the drug were identified as the cause.  
Pyromarkers of either the heroin or impurities present in the samples may have been the 
cause of this condition.16,17   
In all, the increased popularity of smoking drugs of abuse raises much concern about 
drugs that are currently being abused by other routes of administration.  Consequently, little 
is known about whether side effects and toxicity would be increased by smoking.  Table 1 
provides a list of some of the most commonly smoked drugs and prescription drugs of 
abuse.1,2  These drugs listed on this table may be potential targets that can be evaluated using 
these methods developed here.  
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Analytical pyrolysis is the technique of studying molecules either by observing their 
behavior during pyrolysis or by studying the resulting molecular fragments.5  It has 
frequently considered being a technique mainly applied to the analysis of natural and 
synthetic polymers in forms of paints, plastics, adhesives, etc.5,18  Recent work in our 
laboratory has demonstrated the utility of analytical pyrolysis for studying pyromarkers of 
smoked drugs of abuse for cocaine and methamphetamine.19,20 These results have been 
confirmed in literature of toxicological case samples of urine.21,22 The smoking process and 
conditions can be mimicked by interfacing a pyroprobe unit via gas chromatography coupled 
with mass spectrometry (Py-GC/MS).   
The goal of this dissertation is a qualitative study of the pyrolysis of fentanyl and 
fentanyl transdermal patches (FTPs) in the typical route of administration of inhalation 
through the method of “chasing the dragon” (discussed in further detail in Section 1.2.3).  In 
addition, the pyrolysis of heroin mixed with fentanyl is also analyzed to determine significant 
pyromarkers. 
With regard to smoking parameters, literature reviews have provided extensive data 
about manufactured tobacco cigarettes.  Smoking machines have been used that take into 
account puffing and smoldering characteristics of the active process of smoking.   Baker and 
Bishop have done extensive temperature analysis on manufactured tobacco cigarettes and 
have observed high temperatures of 605-770 ºC.23,24  More discussion on manufactured 
tobacco smoking is discussed later in section 3.1.0.  The pyrolysis of fentanyl was initially 
analyzed and modeled after these findings of the manufactured cigarettes.  However, it was 
later determined that temperatures of pyrolysis were much lower by the use of a smoking box 
with temperature probes that was created to observe actual readings of smoking fentanyl.  
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This simple experiment indicated that manufactured tobacco cigarette smoking temperatures 
cannot be directly translated to drug abuse.  These lower temperatures were then applied to 
further pyrolysis analysis. 
Once the pyromarkers are determined, identifying metabolites formed by an in vitro 
breakdown of those compounds may lead to the discovery of a potential marker that could be 
used in human studies.  Human lung and liver microsomes containing cytochrome P450 
could be used for metabolic studies of the pyromarkers in the future. 
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Table 1-1.  Common smoked drugs of abuse with the DEA drug schedule.2,25 
Substance: Category & 
Name Examples of Commercial and Street Names 
DEA 
Schedule  
Tobacco     
Nicotine 
Found in cigarettes, cigars, bidis, and smokeless 
tobacco (snuff, spit tobacco, chew)   
Cannabinoids     
Marijuana 
weed, pot, dope, skunk, sinsemilla, ganja, blunt, 
dope, herb, Mary Jane, reefer, joint, green, trees, 
smoke, bud 
I 
Hashish hash, hash oil, boom, hemp, chronic, gangster I 
Opioids     
Fentanyl and analogs 
Actiq, Duragesic, Sublimase: china white, Apache, 
China girl, dance, fever, friend, goodfella, jackpot, 
murder 8, TNT, Tango and Cash 
I, II 
Heroin 
Diacetylmorphine: brown sugar, skag, smack, horse 
dope, H, junk, skunk, white horse, China white; 
cheese (with OTC cold medicine and antihistamine) 
I 
Morphine Roxanol, Durgamorph: Miss Emma, monkey, M II, III 
Opium 
Laudanum, paregoric: big O, black stuff, block, gum, 
hop II, III, V 
Stimulants     
Cocaine Cocaine hydrochloride: blow, candy, rock, C, 
Charlie, coke, crack, flake, snow, toot 
II 
Amphetamine 
Biphetamine, Dexedrine, Adderall: bennies, speed, 
black beauties, crosses, hearts, LA turnaround, truck 
drivers, uppers II 
Methamphetamine Desoxyn: chalk, fire, ice, meth II 
Methylphenidate Ritalin: JIF, MPH, vitamin R II 
Dissociative Anesthetics     
Ketamine Ketalar SV: cat Valium, Special K, vitamin K III 
Phencyclidine and analogs Phencyclidine: angel dust, boat, hog, love boat, peace 
pill I, II 
Salvia divinorum Salvia, Shepherdess's Herb, Maria Pastora, magic 
mint, Sally-D   
Hallucinogens     






1.2.0 Compounds of Interest 
 
 The compounds of interest in this study were fentanyl and heroin that are classified as 
opiates.  Table 1-2 shows the structure and basic properties of both.  Opiates is a term that 
refers to compounds that are not only derived from the opium poppy, Papaver somniferum, 
but also applies to compounds that are either pharmacologically similar or closely related 
structurally to morphine.3  Narcotic is also a term used and is similar to the opiates that mean 
a central nervous system (CNS) depressant that has a numbing action.  The opium poppy is 
cultivated in temperate climates and is indigenous to Burma, Laos, and Thailand, commonly 
referred to during the last half of the 20th century as the Golden Triangle.26  In addition to 
those three countries, much of the world’s illicit supply of opium is cultivated in 
Afghanistan, Colombia, Mexico, and Pakistan, with Afghanistan being the largest 
producer.26,27  Opiates are typically divided into the naturally occurring, semi-synthetics and 
synthetics. Morphine and codeine are naturally occurring opiates.  Semi-synthetics that are 
manufactured most easily by using starting materials that are themselves opiates are 
considered as hydrocodone, hydromorphone, oxycodone, oxymorphone, and heroin.  
Fentanyl is a synthetic opiate that may be prepared by synthesis from non-opiate precursors. 
 The mechanism of action of opiates begins with the opioid receptors within the brain, 
spinal cord, and other organs which structures bind natural, endogenous compounds known 
as endorphin peptide transmitters or beta endorphins.3  The endorphins bind to the opioid 
receptors that allow for the diminishing of the perception of pain throughout the pain 
pathway.  Opiates enhance the opioid receptor response by stimulating these receptors in a 
manner similar to that induced by the natural compounds, endorphins.3  The binding of the 
receptor by the endogenous compound, beta endorphins, or the exogenous opiates inhibits the 
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release of a specific neurotransmitter or the substance P in the pain pathway.  Opioid 
dependency is believed to be related to the opioid receptors existing within the limbic 
system.  It is this part of the brain that is related to the drug dependence.  It is this binding of 
the opiates within the limbic system that is presumably associated with the drug dependence 
that develops within the user.    
 The four kinds of opioid receptors are listed in the Table 1-3.  The δ and μ receptors 
have the same functions, but are located in different regions.  Receptor stimulation causes 
euphoria, analgesia, sedation, and respiratory depression.  Those overdosed on opiates are in 
CNS depression with side effects ranging from lethargy to deep coma.3  Severe, acute 
overdose may result in death and is preceded by respiratory depression to the point of apnea, 
myocardial depression, rhabdomyolysis, seizures, and coma.  The antidote of choice is 
naloxone (Narcan®), which is a pure opioid antagonist that has no actions that are additive to 
those of opiates.3  Naloxone displaces the opiate molecules form their receptor sites in the 
brain.  Within 1 or 2 minutes respiration is dramatically improved with a dose of just 0.4 
mg.3  Depending on the severity of overdose, naloxone is given repeatedly since it has a short 
half-life of about 60 min.3 
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Table 1-2.  Properties and strucutre of fentanyl and heroin.28,29 












Molecular Formula C22H28N2O C21H23NO5 
Molecular Weight  336.5 g/mol28 369.4 g/mol 
pKa 8.44 7.6 
Solubility Soluble in water and alcohol Soluble in water, alcohol, and 
chloroform 
Melting Temperature  83-84 °C 173 °C 
Toxicity 2 mg 200 mg 





Table 1-3.  Opiate receptors. 
Receptor Location Actions 
Mu (μ) Cerebral cortex, thalamus Analgesia, respiratory depression dependence, euphoria, constipation 
Delta (δ) Frontal cortex, limbic system Euphoria, analgesia, respiratory depression 
Kappa (κ) Spinal cord Spinal analgesia, sedation, physical dependence, miosis 





Fentanyl is a lipophilic synthetic opiate used for anesthesia and analgesia.  It was 
originally synthesized in Belgium in the late 1950s and patented by Janssen-Cilag 
International 1963.30  It was introduced to the United States in the 1970s for the use in the 
induction of anesthesia and the relief of postoperative pain.31  Aside from clinical therapeutic 
pertinence, it is the euphoric effects of fentanyl that are sought after by drug users, making it 
increasingly popular as a choice drug of abuse.27,31-35  Fentanyl is approximately 50 to 100 
times more potent than morphine and 30-50 times more potent than heroin depending on the 
physiological or behavioral endpoints being measured, the route of administration, and other 
factors.36  
Fentanyl may be administered by the transdermal route in a form of the FTP as an 
effective alternative to oral morphine in patients with stable opioid requirements.37,38  In 
particular, in patients who are not able to take oral medication, it provides a continuous 
delivery of fentanyl and is a less invasive alternative to subcutaneous opioid infusion.37,38  
The form of fentanyl used in the FTPs is fentanyl citrate.  The fentanyl citrate has a higher 
melting point of 153-154 ºC, instead of 83-84 ºC as noted in Table 1-2.39  FTPs are often 
obtained through the black market, prescription fraud, and improper disposal.  The reservoir 
FTPs has been in use since the early 1990s, but was associated with misuse and was 
consequently discontinued and phased out by most companies by 2009.31-33,38,40,41  Janssen-
Cilag International developed the Durogesic® D Trans® developed the matrix FTPs (Figure 
1-1B) after the initial reservoir FTPs (Figure 1-1A).  To limit the potential of fentanyl abuse 
by the extraction of the fentanyl gel from the drug reservoir of the FTPs, an alternative 
generation of transdermal matrix FTP was developed where the active drug is dissolved in a 
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semi-solid polymer matrix.  Other companies have developed different technologies of the 
matrix FTPs, such as Martifen (Nycomed Roskilde, Denmark), where fentanyl-containing 
dipropylene glycol droplets dispersed in a silicone matrix.  The plastic matrix makes the 
patches far less suitable to transbuccal use and far more difficult to use illicitly than its gel 
filled counterpart.  
There have been reports of abuse of reservoir FTPs by the following pathways: oral 
ingestion by either licking or chewing on the FTP;42 intravenous injection;43 transdermal 
application of multiple patches cutaneously;44 rectal insertion;45 and inhalation by 
volatilization.41  One of the first reported cases of death by inhaled fentanyl was published by 
Mardquardt et al. in 1994.41  The fentanyl in a gel matrix was scraped off the drug reservoir 
of a FTP, heated on aluminum foil, and then inhaled.  Another means of intoxication is by 
smoking illicitly manufactured fentanyl laced with heroin or cocaine, both of which are 
reported to have been prevalent in Delaware, Illinois, Maryland, Michigan, Missouri, New 
Jersey, and Pennsylvania.36  
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Figure 1-1.  Schematic representation of a reservoir type patch (A) and a matrix 
type patch (B). 
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Fentanyl is rapidly metabolized in the liver and intestinal catalyzed by CYP3A4.46  
Norfentanyl and despropionly fentanyl are two commonly reported metabolites of fentanyl in 
the human body produced by piperidine N-dealkylation and amide hydrolysis, 
respectively.46,47  There is a significant overlap between therapeutic and toxic fentanyl 
concentrations in serum.31  Typical therapeutic and toxic fentanyl concentrations in serum are 
1–3 ppb and >3 ppb, respectively.31,41,42  However, there are some reports of fentanyl deaths 
from as low as 2 ppb33 and therapeutic concentration of 8-9 ppb perhaps due to gain in 
tolerance.35  Tolerance simply refers to a phenomenon in which the exposure to a drug results 
in the diminution of an effect or the need for a higher dose to maintain an effect that is 
dependent on genetics and/or acquired tolerance.48  Therapeutic concentrations can be even 









 Heroin (diacetylmorphine) was first synthesized and introduced into clinical practice 
over 125 years ago as a non-addictive treatment for soldiers since they had become 
physically dependent on morphine during the American Civil War.26  In North American, 
heroin obtained are primarily produced illicitly in clandestine chemical laboratories located 
in Colombia, France and Italy.26  In the 1980s, primary route of administration of heroin was 
through intravenous injection.  However, the risk of transmitting HIV through shared needles 
and the increased availability of significantly purer form of heroin from 5% to over 90% the 
preferred route of administration had shifted to intranasal snorting and smoking.26  Intranasal 
snorting of heroin can cause acute, potentially life-threatening exacerbation of asthma.  With 
a short elimination half-life, heroin is not detectable in plasma after oral or rectal 
administration. 
 When heroin is orally ingested, it is rapidly deacetylated in the liver and GI tract and 
undergoes first-pass hepatic metabolism, to morphine.26  Therefore, heroin offers no 
advantage over morphine and similarly, heroin offers no advantage over methadone in 
opiate-dependence maintenance programs.26  Esterase enzymes that are present in the blood, 
the liver, and the brain rapidly converts heroin to 6-monacetylmorphine (6-MAM) and 
morphine (Figure 1-3).7,49-51   
Literature reports have suggested that deacetylation (hydrolysis) of 6-MAM to 
morphine is significantly impaired by the presence of high blood alcohol concentrations 
which has been postulated to contribute to the higher rate of heroin over dose deaths when 
alcohol intoxication is simultaneously present.26  Administration through intravenous 
injection rapidly deacetylates heroin to 6-MAM with which is further deacetylated to 
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morphine and undergoes metabolism to morphine-3-glucuronide and morphine 6-O-
glucuronide.26  The elimination half-life of heroin after intravenous injection is 1.3 to 2.2 
min.26  Even in laboratory analysis, heroin hydrolyzes in aqueous solution to 3-O-
monoacetylmorphine (3-MAM) and 6-MAM and morphine to a significant extent at room 
temperature.52  
 The dangers of intravenous administration of heroin are increased due to many 
possible health complications that typically result from the bad quality of the product.  The 
quality of the heroin can be limited by impurities, adulterants, diluents, and contamination 
with microorganisms.53-56  Inhalation of heroin therefore poses several advantages over 
intravenous administration besides blood-borne infectious diseases.  Through inhalation, a 
given dose takes more time to consume that allows the abuser to have more control of the 
dosage and lessens the risk of drug overdose.7  In addition, the toxicity to systemic exposure 
to impurities and adulterants present in street heroin is less likely since there some will not be 
volatilized for inhalation exposure.7  Conversely, the heating of street heroin will cause 
degradation of components present that could be of more health hazardous than intravenous 




Figure 1-3.  Heroin Metabolism. 
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When heroin is heated to produce vapors for inhalation, significant amounts of the 
drug is decomposed during the heating process.  In 1985, Cook and Brine studied the 
pyromarkers of both heroin and heroin HCl using 20-41 mg of drug on a quartz boat and 
connected with dry and bubble traps to collect the pyromarkers.  The traps were solvent 
washed and the collected pyromarkers were analyzed by a combination of proton and 13-
carbon NMR and MS.  It was determined that 6-MAM, N,6-O-diacetylnormorphine, and 
N,3-O,6-O-triacetylnormorphine were the major pyromarkers at 250 °C, with 3,4-
diacetoxyphenanthrene being the minor pyromarker found (Figure 1-4).57-59   
Unlike fentanyl, the potency of heroin administration is lowered through the route of 
inhalation rather than injection.  This can be evaluated by the effective median dose (ED50).  
Heroin was somewhat less potent than by inhalation (ED50 1.9 μmol/kg) administration than 
intravenous injection (ED50 of 0.69 μmol/kg).60  In contrast, a similar compound like 
morphine has a higher potency by inhalation (ED50 0.77 μmol/kg) administration than 
intravenous injection (ED50 3.9 μmol/kg).60  This is likely due to the fact that 6-MAM was 
found to be more potent at the μ-receptors than morphine.  Although 6-MAM is a major 
pyromarker, it accounted for less than 5% of the recovered sample in one study,60 whereas, 
heroin rapidly converts to 6-MAM in the blood stream during intravenous injection.  The 
exposure to 6-MAM is higher during intravenous injection rather than inhalation.  Inhalation 
exposure to heroin produced significantly more analgesic effects when volatized at 250 °C 
than at 200 °C.60    
In 1987, Huizer evaluated the volatization of heroin under a variety of conditions, 
particularly in the presence of various diluents often used in the smoking process.61  “Heroin 
pills” or “red pills” were seen as early as the 1920s in China, which were mixtures typically 
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of heroin, caffeine, a cinchona alkaloid (quinine cinchonine, or cinchonide), strychnine, and 
aspirin or salicyclic acid mixed with starch, cane sugar or lactose, perfume and dye to color 
the pills.62  Today, typical diluent for heroin smoking are caffeine, strychnine, lactose, 
acetaminophen, and diphenhydramine.26,57,63-65 Studies have shown that caffeine enhanced 
the volatilization and changes the ratio of the pyromarkers with 6-MAM to be the most 
abundant.66  Thus, the amount of heroin inhaled by smoking is strongly dependent on the 
presence of the diluents.  Diluents can also influence the ratio of the pyromarkers. 
 Near the end of 2005 and early into 2006, the government and media reported an 
increase in the number of individuals who have overdosed on heroin that was laced with 
fentanyl as a diluent.  The largest number of reported fatalities was in Chicago, in addition 
with Pittsburgh, St. Louis, and Camden, New Jersey reporting cases as well.67  It was thought 
that these samples were sold by a network or gang that was producing tainted heroin; to 
counter this, they added fentanyl to improve the low quality heroin.  The first time drugs 
were mixed with fentanyl were sold on the street was documented in Orange County, CA, in 
1979.68  As previously noted, the pyromarkers of heroin are known.  However, the 




Figure 1-4.  Known pyromarkers of heroin. * Denotes minor pyromarker. 
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1.2.3 Smoking Opioids by “Chasing the Dragon”  
 
The coming of the method “chasing the dragon” is due in part to the smoking of 
heroin.  The first report of heroin smoking originated in Shanghai, China, in the 1920s, where 
it then spread across much of Eastern Asia and to the United States over the next decade.69  
The smoking of heroin existed alongside the longer established use of opium both by 
swallowing and by smoking.69  Early accounts of heroin smoking involved smoking heroin 
pills in which small china jar or porcelain vase into which a hole had been drilled and 
through which the heroin pill was heated gently so that the heroin smoker could inhale the 
fumes of the pill through a bamboo tube.62,69  
An early account of “chasing the dragon” is described in Bulletin on Narcotics, 1958. 
Cheap crude quality heroin that is typically unfit for injection, had a tendency to run into a 
single mass when heat was applied and the outsides became charred creating a heat barrier 
resulting in an incomplete combustion.70  A barbiturate, commonly known at the time as 
“daai fan,” was sold with the crude heroin which prolonged the effects of the heroin and 
aided in the sublimation during heating.71  The refinement of the technique soon utilized a 
piece of foil, a straw, and cardboard.  Both base powder and heroin placed half an inch apart 
in the crease of the foil where then the flame from the lit piece of cardboard is applied.  The 
foil is then tilted back and forth whilst the flame is applied directly under the crease; at the 
same time the smoker directs the straw, which is held in the mouth over the foil and inhales 
the fumes emanating from the heated mixture.70  To obtain the best effect the abuser chases 
the “smoky tail” of the liquid with the straw in mouth while moving the foil back and forth 
over the flame until nothing is left on the foil except for a black stain.70  For this reason, the 
whole procedure was phrased as “chui lung” or “chasing the dragon.”70 
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Today, websites and blogs showcase stories of individuals of utilizing this method for 
abusing fentanyl and FTPs.72-74  Prior to the dwindling manufacturing of drug reservoir FTPs, 
abusers would extract the fentanyl gel from the drug reservoir and placed it on a piece of 
aluminum foil, heated with a lighter until it sizzles, and then vapors are inhaled through a 
straw or pen casing.  Matrix type FTPs were smoked similarly by placing pieces of the FTPs 
on foil, thus introducing the pyrolysis of plasticizers and adhesives that were incorporated in 
the manufacture of the FTPs.  
 
1.3.0 Methods of Degradation 
 
Pyrolysis is a process that breaks the chemical bonds of a compound using thermal 
energy.  The products produced by pyrolysis are typically referred to as pyrolytic products.  
To study the pyromarkers of fentanyl, recent work in this laboratory has demonstrated the 
utility of analytical pyrolysis.75,76  Heating fentanyl beyond a certain temperature will allow 
for thermal degradation since its chemical bonds have a limited thermal stability.  These 
chemical changes are similar to those occurring during the smoking process and high 
temperature conditions.   
Analytical pyrolysis allows for reproducible control of parameters such as 
temperature, heating rate, and atmosphere.  This enables researchers to study the 
fragmentation products that are characteristic of the parent compound.77  Fragmentation is 
primarily based upon the bond strengths between each atom of a molecule, where weaker 
bonds are broken first.  Thermal degradation reactions, given from most common to least, 
include eliminations, fragmentation, rearrangements, oxidations, reductions, substitutions, 





Figure 1-5.  Scheme of common degradation mechanisms observed in pyrolysis. 
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Pyrolytic elimination is the most common amongst the above processes.  Elimination 
does not always take place from the 1,2 positions, and depending on which atoms are 
involved in the elimination, these reactions are classified as α-eliminations, β-eliminations, 
1,3-eliminations, etc.78  Based on their mechanism, these eliminations has an radical Ei 
mechanism or in unusual cases an E1 or E2 mechanism.78  Since pyrolytic elimination takes 
place with no other reagent present and often requires gas phase, the typical E2 mechanism 
where a proton is pulled by a base is not common.77 
Pyrolytic α-eliminations involve two leaving groups connected to the same carbon 
(Figure 1-6A).  Typically α-eliminations are encountered when the more common β-
elimination is not possible.  Pyrolytic β-eliminations are the most common type of 
elimination reactions that take place typically by an Ei mechanism with two groups lost from 
adjacent atoms (Figure 1-6B).  If a double bond is present during an Ei type pyrolytic 
reaction the formation of a conjugate system is preferred if sterically possible.  Otherwise, 
the orientation in the pyrolytic elimination is statistical and is determined by the number of β-
hydrogens.  Any newly formed double bond goes toward the least substituted carbon as 
governed by Hofmann’s rule.78 
In addition, there are eliminations involving free radicals that are frequent at 
temperatures between 600 ºC and 900 ºC.78  The initiation reaction typically takes place with 
a high probability at the bonds with a lower energy, whereas at higher temperatures, even 
bonds with higher energy are cleaved.78  Figure 1-7 shows a generic elimination involving 




Figure 1-6.  Pyrolytic Elimination Reactions. 
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𝐈𝐧𝐢𝐭𝐢𝐚𝐭𝐢𝐨𝐧:  R2CH − CH2X
∆
→ R2CH − CH2∙ + X∙ 
𝐏𝐫𝐨𝐩𝐚𝐠𝐚𝐭𝐢𝐨𝐧:  R2CH − CH2X + X∙ → R2C∙ − CH2X + HX 
R2C∙ − CH2X → R2C = CH2 + H∙ 
𝐓𝐞𝐫𝐦𝐢𝐧𝐚𝐭𝐢𝐨𝐧:  2R2C∙ − CH2X → R2C = CH2 + R2CX − CH2X 
2X∙ → X2 
R2C∙ − CH2X + X∙ → R2C = CH2 + HX 
𝐅𝐢𝐧𝐚𝐥:  R2CH − CH2X
∆
→ R2C = CH2 + HX 
Figure 1-7.  Pyrolytic elimination reactions involving free radicals. 
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The nature of molecular fragments generated in pyrolysis is analogous to ion 
formation in electron impact mass spectrometry.78  The difference is that during pyrolysis, 
there are no ions formed because the energies involved in the pyrolytic process are much 
lower than the required ion formation.  Also, pyrolysis can be done on many molecules in 
condensed phase and can be performed at different temperatures.78  Figure 1-6B is an 
example of a Grob fragmentation where one carbocation is the leaving group.     
Rearrangements are very common in pyrolytic reactions following eliminations and 
fragmentation.  Rearrangement reactions involve an atom or migration group moving from 
one place to another on the same molecule.  Figure 1-6C is an example of a 1,2 shift that is a 
common rearrangement reaction.  Rearrangement can also be observed in positions that are 
farther apart and usually involves a free radical being formed followed by a free radical 
rearrangement occurring between the two positions.77 
Oxidations, reductions, substitutions and additions more commonly follow an initial 
step that produces a elimination, fragmentation, or a rearrangement.78  However, these 
reactions may sometimes be the first step in pyrolysis and are caused by higher reaction rates 
as a result of increased temperature.  In general, all of the degradation products, as well as 
minor constituents and deviations can be simplified in three statements: 1) the mechanism 
behind degradation involves free radical processes and are initiated by breaking the weakest 
bond first; 2) pyromarkers are based on the stability of the free radicals involved and on the 
stabilities of the product molecules; 3) free radical stability follows the order of 3° > 2° > 1° 
> CH3.5  
To mimic realistic smoking conditions, pyrolysis must be performed in the presence 
of additional catalysts such as oxygen, water and hydrogen.  This can be explained by 
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considering oxygen, which has the properties of a diradical, since in its ground state each of 
the two higher occupied molecular orbitals contain an unpaired electron.  Figure 1-7 shows 
that diradical oxygen can rapidly react with many other radicals in a chain oxidation.  Since a 
pyrolysis reaction typically generates free radicals, the formation of hydroxyperoxide is 
likely.  Oxygen may also react at the elevated temperatures with the parent compound that is 
subject to pyrolysis.78 
The pyrolysis process can be more than the decomposition of one single molecular 
species, since the products of the initial decomposition may undergo further reaction under 
the influence of heat.  Also, the initial process can be unique or more pyrolytic reactions 
occurring simultaneously can contribute to the generation of the pyromarkers.  Even the 




R. + O2 → ROO. 
ROO. + RH → ROOH + R. 




 A thermocouple was used in this work for measuring temperatures associated with 
smoking FTPs by means of “chasing the dragon.” The pyrolysis gas chromatography/mass 
spectrometry (Py-GC/MS) was used to mimic analytically the smoking conditions to analyze 
the products produced by application of different temperatures of heat.  
1.4.1 Thermocouple 
The thermocouple is one of the most common temperature transducers that essentially 
convert thermal energy to electric energy.  It is the amount of electric energy that is 
produced, that can be used to measure the temperature, which is based on the continuous 
current that flows in the thermoelectric circuit.  T. J. Seebeck discovered this 
thermoelectricity in 1821.  It was first suggested that this could be used for high temperature 
measurement within five years of this discovery by A.C. Becquerel.79  Seebeck’s work 
showed that a small electric current will flow in a close circuit composed of two dissimilar 
metallic conductors when their junctions are kept at different temperatures.80  In Figure 8a, 
the current flows from the positive metal C with respect to metal B at the hot junction where 
temperature is measured.  Under these conditions, the electromotive force (emf) is produced 
and is known as the Seebeck emf.  It is the pair of conductors, or thermocouple elements, 
which constituted the thermoelectric circuit that is called a thermocouple.80  If this circuit is 
broken at the center, the net open circuit voltage (the Seebeck voltage) is a function of the 
junction temperature and the composition of the two metals.81  All dissimilar metals exhibit 
this effect and for small changes in the temperature the Seebeck voltage is linearly 
proportional to temperature (eq. 1). 
∆𝑒𝐴𝐵 = 𝛼∆𝑇                                                        (eq. 1) 
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Where α is the Seebeck coefficient that is constant of proportionality, T is the temperature 
and eAB is the Seebeck voltage.   
The cold junction of the thermocouple is connected to a voltmeter and the leads of the 
voltmeter themselves create a new thermoelectric circuit (Figure 1-9B). Higher the 
temperature difference creates higher voltage.  The right pair of metals is needed to measure 
the targeted temperatures of 20 K to 2000 K.  There is seven “standardized thermocouples” 
with different alloy combinations that has internationally agreed reference tables for thermal 
emf vs. temperature with letter designations82.  Base metal thermocouples are composed of 
inexpensive metals like nickel, iron, and copper.  The thermocouple types, E, J, K, N, and T 
are among this group.  These are the most commonly used type of thermocouple.  Each leg of 
these different thermocouples is composed of a special alloy, which is usually referred to by 





Figure 1-9.  Schematic of A) the basic thermoelectric circuit and B) a practical circuit 
for thermocouple voltage measurements. 
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1.4.2 Py-GC/MS  
 
The components of a pyroprobe unit consisted of a pyroprobe, trap, accessory, valve 
oven, and the transfer line (Figure 1-10).  The pyroprobe is interfaced with a heated transfer 
line to a GC/MS with an electron ionization source and a single quadrupole mass analyzer.  
For most commercially available pyrolyzers, the sample size should be in the low microgram 
range to produce better results than larger ones.83  The unit consist of three modes of 
operation that include: Clean, to remove residual material from the filament; Dry, to remove 
solvent from a sample deposit; and Run, for pyrolysis of the sample to be analyzed.  Here, 
solid samples of approximately 10-100 μg are sandwiched between quartz wool inside the 
quartz tube.  Liquid samples of approximately 10 μg are injected in the middle of the quartz 
wool plug inside the quartz tube and put through the dry method prior to pyrolysis.  The 
quartz tube is inserted into the platinum coil filament of the pyroprobe and is capable of 
reaching temperatures of up to 1400 °C at rate of 0.01 °C/min to 2000 °C/s.84  The 
microprocessor of the unit controls the temperature of the filament by calculating the 
resistance of the filament at setpoint temperature and supplying the correct voltage to achieve 
that temperature.84  The pyroprobe is inserted inside the heated chamber, known as the 
accessory region, of the pyrolysis unit on the left of Figure 1-10.   
The unit can operate in both non-trap and trapping modes.  The use of the trap allows 
the pyrolysis to be performed in a different atmosphere from the carrier gas.5,18,85  In trapping 
mode, there is a second heated zone connected to the valve oven, which there is an option to 
add a reactant gas, such as air, to the volatile sample in the trap region.  Figure 1-11 is a 
representation of the pyroprobe temperature program in non-trapping mode and trapping 
mode.  In trapping mode, the sample is swept into the trap that is shown with a dotted line.  
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As the pyroprobe is being heated by a controlled ramp rate inside the valve oven, the reactant 
gas carries the volatile components to the sorbent tube trap packed with 20:35 mesh Tenax-
TA.  The Tenax-TA is 2,6-diphenylene oxide that is commonly used for thermal desorption 
and is stable below 350  °C.86   The combination of interface and trapping programs allows 
any volatile compounds to be vented during the interface program.  The pyroprobe would 
then fire after the 8 port valve rotor had rotated to allow any pyrolysis and oxidation products 
to be collected on the trap.  During the last minute of flow to the trap, the carrier gas is 
automatically changed to helium to remove the residual air from the trap before desorption of 
analytes to the GC-MS for continuous separation and detection using the transfer line.  In 
general, the desorption temperature should be at least 20 °C above the boiling point of the 
adsorbed compounds, so the range of compounds which can be analyzed with thermal 










Figure 1-11.  Representation of pyroprobe temperature program in trapping mode, 





In the GC used in this research, the mobile phase is gaseous and the stationary phase 
is a tethered liquid inside of silicon capillaries.  The partitioning of analytes between the 
stationary and mobile phases facilitates chromatographic separation.  As the analytes move 
through the capillary, the analyte partitioning reaches equilibria.  In chromatography, 
retention time of an analyte is a factor of dead time (time for the mobile phase to reach the 
detector) and time spent in the stationary phase. 
 The GC composed of the following: a gas supply (mobile phase); pressure regulators, 
gauges, and flow meters to control and maintain a constant flow rate; a sample injection 
chamber; a column contained in a thermostatted oven; and a detector that is networked to a 
data collection system.87 For this research a quadrupole mass spectrometer was used as a 
detector, a standard detector available in forensic laboratories. 
 A mass spectrometer consists of three zones: an ionization region, a mass analyzer, 
and a detector.  In this research, electron ionization (EI) was used to transition gas phase 
molecules to gas phase ions for mass spectrometric detection.  Since GC and EI require the 
sample to be stable and volatile, coupling these two methods is ideal.  The EI requires the use 
of an ion beam to react with and ionize analytes as they exit the column.  It is classified as 
hard ionization which means fragmentation is usual and may be extensive.  This can be 
advantageous by means that EI can provide the molecular mass and structural information of 
the molecule. The molecular ion M+ may form, but generally this ion contains too much 
energy and fragments, therefore, under reproducible conditions (70 eV), EI spectra may be 
used to build searchable databases of fragmentation patterns.  A large number of organic 
molecules that are less than 600 Da can be ionized using EI and well over 100,000 spectral 
library databases have been developed and accessed through most GC/MS software.88 
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Limitations of using EI are the requirement of volatile and stable samples.  Unstable 
compounds may over fragment to a point that the molecular ion cannot be determined from 
the mass spectrum that can return provide no structural information. 
 A quadrupole mass analyzer was used as the detector in this portion of the study.  A 
quadrupole mass analyzer features four hyperbolic poles with oscillating applied DC and RF 
potentials.  The RF signal influences the trajectory of light ions while the DC signal 
influences the trajectory of heavy ions.  If an ion is destabilized by the oscillating signals, it 
will collide into the quadrupoles and lose charge.  Stable ions travel through the quadrupole 
to the detector.  The quadrupole mass analyzer may be scanned such that ions of varying 
mass to charge ratios arrive at the detector to form a spectrum.  For detection, an electron 
multiplier was used.  An electron multiplier is used to amplify signal (with a typical gain of 
106 to 1011 electrons) prior to arrival of electrons at a Faraday cup.88  A Faraday cup is 
grounded and as electrons strike a current is generated and measured.  Identification solely 
based on mass spectral comparison using the MS database provided tentative identification of 
the analytes.  Whilst, identification based on the database and standard reference materials 
(SRMs), where both retention time and MS spectra were compared, provides confirmatory 
identifications.  
Py-GC/MS can provide both qualitative and quantitative information regarding 
pyromarkers.  One common purpose for this technique is to determine the nature of the 
material that was pyrolyzed.  This is possible either through the use of the composition of the 
pyrolytic products as a chromatographic pattern of the parent molecule, or from the similarity 
of the structure of fragment molecules from the pyrolytic product with that parent compound.  
Qualitative analysis in Py-GC/MS is based on the identification of various peaks in the 
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chromatogram with the help of MS database.  The analysis can be limited to the 
identification of the main components in the pyrolytic products, or it may include minor 
components and sometimes trace compounds.   
Py-GC/MS can be applied for quantitative purposes, although less common than 
qualitative analysis.  Quantitative analysis is applied more frequently in polymer analysis, for 
example, in the determination of the amount of a specific polymer in a given complex matrix, 
such as a composite material, inorganic matrix, etc.78,89,90  Quantitative measurement of a 
pyrolysis product can be used successfully even for the analysis of other organic 
molecules.78,89 In order to have a reliable quantitative result by Py-GC/MS, an important 
requirement is the repeatability of the analysis.  It has long been recognized that small 
samples, typically less than 1 mg, good heat transfer and rapid heating of the pyrolysis 
element are essential in achieving reproducibility.77,78,83,89 With same instrumental conditions 
and the same amount of sample, the reproducibility can be good with replicate analysis with 
relative standard deviations less than 1% frequently reported.78,83 Calibration is typically 
necessary by using internal standards, external standards, or a standard addition procedure. 
A limitation to this process is that Py-GC-MS cannot completely mimic all factors of 
the smoking conditions such as humidity, airflow, and fluctuations in temperature.  The 
pyrolysis unit can only perform and alter one temperature condition at a time.  Even with 
these apparent limitations, pyromarkers produced by pyrolysis have been consistent with 
literature reports of smoked markers for cocaine and methamphetamine.21,22,91  Work 
produced by the Bell Research Group, including this research, has led to publications in the 
Journal of Forensic Science and the Journal of Analytical Toxicology, and both have been 
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cited in literature.  Further research on this method will be used to study other smoked drugs 














Chapter 2: Application of the Py-GC/MS to Mimic 





The method by which fentanyl is smoked can influence in the prominent pyromarkers 
observed.  Methods used to smoke fentanyl include: glass pipes, cigarettes, and a method 
known as “chasing the dragon.”  For over 30 years, Baker has been the pioneer on 
manufactured tobacco cigarette studies carrying out extensive analysis on temperature 
distribution and designed effects on tobacco pyromarkers.  As recently as 2005, Baker and 
Bishop had used a similar pyrolysis unit to analyze non-volatile tobacco ingredients.23,24 
Fentanyl smoking studies was therefore be based on what has been learned from 
manufactured tobacco cigarette studies, since cigarettes studies have been the forefront of 
smoking analysis due to its popularity tobacco over many years.  Old dried gel drug reservoir 
FTPs or matrix type FTPs are smoked in a cigarette fashion, therefore the temperature 
distribution can be compared to temperatures which can reach from ambient to about 950 ºC 
in the presence of varying concentrations of oxygen.92 
In general, Baker indicated that smoke from a tobacco cigarette is formed in two 
distinct zones of puffing and smoldering.  The combustion zone takes place in the region of 
the lit cigarette where temperatures generally exceed 600 ºC, called the coal.93  From 
temperatures that can exceed ~900 ºC with heating rates as high as 500 ºC/s at the center of 
the coal in the presence of varying concentrations of oxygen such as during the puff of the 
cigarette.94-97  The second zone, immediately behind the coal, has temperatures below 600 ºC 
and the tobacco is distilled and/or pyrolyzed to produce more chemically complex mixture of 
gases and vapor.98  The generation of smoke is the result of a self-sustaining combustion 
cycle in which occurs puffing and smoldering conditions.  During the puff, air is drawn in 
through the coal increasing the combustion rate and the coal temperature, with a typical puff 
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cycle of 2 s, can achieve heating rates as high as 500 K/s.95  During the puff, the smoke 
generated during travels through the tobacco column.  These mixtures of hot gases/vapors 
cool as they transfer down the column.  As the distance from the coal to the filter reduces, the 
average temperature in the tobacco column increases, permitting more of the higher 
molecular weight compounds to remain in the vapor or aerosol phase.95  The result is a more 
concentrated mainstream smoke further down the column as the tobacco is smoked.   
During smoldering, combustion is maintained by convective flow around the burning 
zone that utilizes the natural airflow to carry the gases and vapors.  Baker goes into further 
detail that incorporates distinction generation sites for side stream smoke.  However, the 
author indicates that little change occurs in the oxygen concentration and temperature 
profiles of the side stream cigarette smoke, even during the puff.99  By this, the authors 
demonstrated the independence of the combustion processes occurring at the surface and 
within the burning zone. 
The intensity, duration and number of puffs, depth of inhalation, degree of mixing of 
smoke with air, and other factors influence the dose making smoking parameters complex to 
mimic.8  The absorption and bioavailability of inhaled drugs vary from person to person and 
potentially from smoke to smoke permitting the smoker considerable latitude in adjusting the 
dose to desired levels.8  Although these limitations are apparent and difficult to mimic using 
analytical pyrolysis, the products produced by pyrolysis of methamphetamines studied 
previously have been consistent with literature reports of smoked markers.20-22,91,100 
Although fentanyl produces the greatest analgesic effects is when it is volatilized at 
300 °C, it is perceived that most drug abusers do not ascertain this temperature while 
smoking the drug.60  Based on the reported average temperature during the rested smoldering 
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of coal for a manufactured tobacco cigarette93,95 and the recent successful pyrolysis analysis 
on cocaine and methamphetamine,20 750 ºC was used to assess pyromarkers of fentanyl here.  
In addition, the pyrolysis unit is utilized in the trapping mode to afford collection of the 
pyromarkers and the use of a reactant gas as the carrier gas without introducing that gas to 
the GC.  The reactant gas used here for analysis was helium and air for both anaerobic and 
aerobic conditions, respectively. 
 
2.2.0 Materials and Methods 
 
Pyridine, benzaldehyde, benzyl chloride, phenylacetaldehyde, (2-
chloroethyl)benzene, propionanilide, and methanol were purchased from Sigma Aldrich (St. 
Louis, MO, USA). Fentanyl HCl was provided by the Department of Basic Pharmaceutical 
Sciences at West Virginia University. Norfentanyl oxalate was purchased from Cerilliant 
(Round Rock, TX, USA). Despropionyl fentanyl was purchased from Biomol (Plymouth 
Meeting, PA, USA). Unopened Duragesic® 75 μg/h reservoir FTPs were recovered from 
cases at the West Virginia Office of the Chief Medical Examiner. 
2.2.1 Py-GC/MS 
 
A CDS Analytical 5200 Pyroprobe was used in trapping mode to pyrolyze the 
samples under anaerobic and aerobic conditions using helium and air, respectively (CDS 
Analytical, Inc., Oxford, PA, USA).  The sorbent tube traps were purchased from CDS 
Analytical, Inc.  One was packed full with 20:35 mesh Tenax-TA and the other was one half-
glass filled with glass beads and the other half filled with 20:35 mesh Tenax-TA.  The 
pyroprobe was interfaced with a heated transfer line to a Perkin Elmer Clarus 500 GC/MS 
(PerkinElmer, Wellesley, MA, USA). The GC was equipped with an Equity-5 column (30 m, 
0.25 mm, 0.25 μm film thickness, Supelco, Bellefonte, PA, USA).  The MS was equipped 
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with an electron ionization source and quadrupole mass analyzer with a scanning range of 
m/z 50–600. 
The components of the CDS pyroprobe unit consist of the pyroprobe, trap, accessory, 
valve oven, and transfer line (Figure 1-10).  Solid sample analyses were performed by 
sandwiching 50-100 μg of fentanyl HCl between quartz wool inside the quartz tube.  The 
quartz tube was inserted into the platinum coil filament of the pyroprobe.  Each Duragesic® 
75 mcg/h reservoir FTP contains 7.5 mg of fentanyl.101  Less than 6% of the gel matrix was 
extracted from the drug reservoir for each run (Figure 1-1A).  The pyrolysis and GC 
conditions for solid fentanyl HCl and the gel from the reservoir of the patch are presented in 
Table 2-1.  Solid fentanyl HCl and the FTP gel samples were analyzed using anaerobic and 
aerobic conditions.  All samples were analyzed in triplicate to establish precision.  Under the 
anaerobic conditions helium was used as the carrier gas in the pyroprobe and GC unit.  For 
aerobic conditions, air was used as the reactant gas and helium was used as the carrier gas. 
Figure 2-1 is a representation of the pyroprobe temperature program in trapping 
mode.  As the pyroprobe is being heated, the reactant gas carries the volatile components to 
the sorbent trap.  During the last minute of flow to the trap, the carrier gas is automatically 
changed to helium to remove the residual air from the trap before transferring the trap to the 













Pyroprobe Conditions   
    
Pyroprobe Temperatures   
Initial 50 °C, 1 s 
Ramp Rate 20 °C/s 
Final 750 °C, 10 s 
Accessory Parameters   
Rest 50 °C 
Initial 90 °C, 1 min 
Ramp Rate 100 °C/min 
Final 350 °C, 5 min 
Trap Temperatures   
Reactant Gas 7.10 min 
Rest 50 °C 
Desorb 300 °C, 2 min 
Iso Zones   
Transfer Line 305 °C 
Valve Oven 305 °C 
    
GC Conditions   
Injector Port 305 °C 
Initial 70 °C 
Ramp Rate 15 °C/min 
Final 325 °C, 3 min hold 
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Figure 2-1.  Schematic of a pyroprobe unit coupled to a GC/MS. 
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2.3.0 Results and Discussion 
 
The pyromarkers of fentanyl HCl and FTPs under anaerobic and aerobic conditions 
are listed in Table 2-2.  Pyromarkers were initially identified using the National Institute of 
Standards and Technology (NIST) MS library.  Identification was confirmed by analysis of 
SRMs and comparison of retention times and mass spectra.  Styrene and aniline were the 
only pyromarkers that were tentatively identified solely by NIST MS database.  The percent 
areas of each pyrolytic product were normalized relative to the largest peak area in the 
chromatogram.  Under all conditions, propionanilide resulted in the largest peak area in the 
chromatograms under both anaerobic and aerobic conditions.  
Norfentanyl and despropionyl fentanyl are two commonly reported metabolites of 
fentanyl in the human body by piperidine N-dealkylation and amide hydrolysis, 
respectively.46  Despropionyl fentanyl, aniline and phenylacetaldehyde were only observed 
under anaerobic conditions of the pyrolysis of fentanyl HCl.  Norfentanyl and benzyl 
chloride were observed only in aerobic conditions of the pyrolysis of fentanyl HCl.  Figure 2-
2 displays commonality and differences in pyromarkers under the both anaerobic and aerobic 





Table 2-2.  Pyromarkers of fentanyl and FTPs under anaerobic and aerobic conditions.  
  Anaerobic Area % Aerobic Area % 
Fentanyyl HCl Pyridine 35.1 Pyridine 18.7 
  Styrene 36.9 Styrene 17 
  Benzaldehyde 1.1 Benzaldehyde 18.9 
  Aniline 5.4 Benzyl chloride 8.8 
  Phenylacetaldehyde 3.7 Phenylacetaldehyde 16.1 
  (2-Chloroethyl)benzene 7.5 Propionanilide 100 
  Propionanilide 100 Despropionyl fentanyl 1.1 
  Despropionyl fentanyl 1.9 Fentanyl 3.1 
  Fentanyl 6.9     
FTP Pyridine 17.4 Propionanilide 100 
  Styrene 39.8 Fentanyl 7.9 
  Propionanilide 100    






Figure 2-2.  Fentanyl pyromarkers comparisons in anaerobic and aerobic trapping 
conditions.  *Denotes commonly reported metabolites.46 
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2.3.1 Pyrolytic Degradation Pathways of Pyromarkers 
 
Figure 2-3 shows the possible pyrolysis degradation pathways of fentanyl.  The 
pyrolysis degradation mechanisms are typically free radical processes and are initiated by 
breaking the weakest bonds first.5  The compositions of these pyromarkers are typically 
based on the stability of the free radicals involved and the stabilities of the product 
molecules.5  The bond break at F1 of the carbonyl group at the amide site can result in the 
minor pyromarker of despropionyl fentanyl.  Aniline is likely due to the less common α-
elimination on two C-N bonds at F1 and F2 at the amide site.  At temperatures above 700 °C, 
it has been reported that aniline starts decomposing with the formation of benzene, N2, HCN, 
and other molecules including low levels of carbazol.85  Cleaving at F1 and the C-N bond 
(F3) at the piperidine ring of fentanyl allowed for the formation of norfentanyl.   
The formation of propionanilide is possibly a result of the cleavage of the C-N bond 
(F2) at the amide site where a β-elimination reaction occurred with the hydrogen of 
piperidine ring of fentanyl.  The formation of pyridine can be explained by the initial 
formation of free radical during elimination cleaving at F2 and F3.  The unsaturated 
piperidine ring may undergo dehydrogenation producing the pyridine ring.102  
Styrene, phenylacetyladehyde, and (2-chloroethyl)benzene is due to the fragmentation 
at F3 producing a free radical.  The phenyl group, which are sp2 hybridized and more 
electronegative that sp3 hybridized carbon atoms of alkyl groups, were not disrupted.103  In 
the presence of free oxygen, slight differences can be observed.  In its ground state, each of 
the two highest occupied molecular orbitals, which are degenerated, contain unpaired 
electrons, which allows ordinary oxygen the property of a diradical.85  This can react with the 
pyromarker free radical producing phenylacetaldehyde.  Since fentanyl HCl salt was used for 
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analysis, free radical halogenation can occur, which may explain the results of (2-
chloroethyl)benzene. 
The cleavage of the C-C bond (F4) next to the nitrogen at the piperidine ring of 
fentanyl likely caused the formation of benzaldehyde and benzyl chloride.  It is feasible that 
these similar elimination reactions, as previously mentioned, produce free radicals that react 
with oxygen and chlorine to produced benzaldehyde and benzyl chloride, respectively.  
Mass spectral fragmentation patterns were as expected, with one exception.  Based on 
the abundance of propionanilide, it was thought that some form of phenyl-substituted 
pyridine might be observed such as 1,2,3,6-tetrahydro-1-(2-phenylethyl)pyridine (PEP) 
shown in Figure 2-3.   This was of toxicological interest given structural similarities of PEP 
to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), which is a known neurotoxin.104-106 
Under the chromatographic conditions used, this compound, if present, would have been 
detected.  However, none was observed in the total ion chromatograms.  Using known 
spectral data,107 a selected ion monitoring experiment was performed using all the same 
conditions except monitoring ions 187 (M+), 96, 91, 77, 65, and 42.   The compound was not 
observed and it was hypothesized that a rearrangement occurred leading to the products that 
were observed.  
Manral et. al. however, had observed PEP, along with propionanilide, at 500 ºC using a 
direct injection and  no reactant gas.102  Further pyrolysis at 750 °C showed increased 
degradation believed to be formed as a result of intramolecular rearrangements in the parent 
molecule.102 This is of toxicological importance in the observation by Manral et al. that at 
750 °C phenylisocyanate may lead to the formation of hydrogen cyanide, which would be a 
large factor in the toxicity of smoked fentanyl.102  
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Garg et al. also has observed this PEP through thermal degradation of the fentanyl 
residues and not the volatile vapors.  It is explained the fentanyl is converted to PEP and 
propionanilide via solvent mediated thermal β-elimination, followed by N-oxidation, 
protonation, and rapid dehydration.108  Garg et al. explained in detail how PEP is further 
degraded and reacted to form PEP salts and 1-styryl-1H-pyridin-2-one (1-SPO) detected in 








Figure 2-4.  Fentanyl pyromarkers from Manral et al. 
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2.3.2 Comparison of Fentanyl HCl and FTPs Under Anaerobic and Aerobic Conditions 
 
A comparison of the pyrolysis of fentanyl HCl and FTPs under anaerobic conditions 
is shown in Figure 2-5.   Fentanyl HCl and the FTP pyrolyzed under anaerobic conditions 
produce pyridine, styrene, propionanilide, and fentanyl.  The peaks enclosed by the circle on 
the FTP chromatogram resulted from phthalates and longer chain alcohols.  The remaining 
peaks in the FTP chromatogram could not be identified.  Under aerobic conditions, 
propionanilide and fentanyl were observed in both the pyrolysis of fentanyl HCl and FTP 
(Figure 2-6).  Again, phthalates and long chain alcohols were present throughout the FTP 
chromatogram hindering the identification of the well-defined peaks.  Chlorine-containing 
pyromarkers obtained with the neat drug were not observed for the FTPs since fentanyl in the 
gel reservoir of the FTPs is in citrate salt form.  This difference could potentially be useful as 
an investigative tool. Also, significant long chain alcohols and phthalates were seen and 
likely derived from the gel matrix of the drug reservoir.  Area and peak height ratios were not 
reproducible for the pyrolysis of the FTPs due to difficulty in controlling the amount of gel in 
each sample introduction.   
A trap that consisted of 50% glass beads (60:80) and 50% Tenax-TA (60:80) was 
employed in an attempt to address carryover problems.  It was anticipated that some of the 
fentanyl would condense on the glass beads before reaching the Tenax-TA.  Since the glass 
beads possess minimal sorbent characteristics, they should simply provide a surface area for 
condensation.  The fentanyl should be stripped from the glass beads when the tube is heated.  
However, this trap configuration displayed poor desorption efficiency (Figure 2-7) compared 
to Tenax-TA alone.  Therefore, a full Tenax-TA trap was employed for the remaining 
experiments.   
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 A drawback of using the pyroprobe without a trap is poor chromatography of 
pyridine and styrene following pyrolysis of fentanyl.  This is likely due to their volatile 
properties for the adsorption of the molecules and its physical adherences to the surface of 
the Tenax-TA that allow for the collection and efficient desorption.  In addition, 
identification of some compounds was problematic without the trapping mode.  No 
significant differences were seen beyond this observation.  The trap enhanced the more 
volatile pyromarkers and afforded a positive identification in mass spectral comparison due 






Figure 2-5.  Fentanyl HCl and FTPs in anaerobic conditions. 
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Propionanilide is a major pyromarker that was observed under both aerobic and 
anaerobic conditions in the pyrolysis of fentanyl HCl and FTPs.  Aerobic and anaerobic 
conditions yielded slightly different products in the pyrolysis of fentanyl HCl.  This study 
shows the possibility of differentiation between smoked fentanyl HCl salt and the FTPs. 
Pyrolysis of fentanyl HCl and FTPs resulted in identification of several potential 
pyromarkers distinctive to smoked fentanyl and not seen as typical metabolites.  The 
following was observed consistently in the pyrolysis of the fentanyl HCl under both the 
anaerobic and aerobic conditions: pyridine, styrene, benzaldehyde, phenylacetaldehyde, and 
propionanilide.  Pyridine could be amenable to a simple headspace assay.  When patches are 
smoked directly, a large suite of potential pyromarkers was identified.  In this application, it 
may also be possible to identify what salt form of the drug was smoked based on the 
pyromarkers produced. 
An assessment of actual accrued temperatures of smoking fentanyl patches is done in 
later chapters.  This will focus on any changes and possible differences of pyromarkers at 
different temperatures reached.  The next chapter will discuss the determination of these data 















Chapter 3: Determination of the Temperature 
Characteristics of Smoking FTPs Using the 




3.1.0 Introduction  
 
The previous chapter has discussed the pyromarkers at a temperature that was 
determined through the analysis of manufactured tobacco cigarettes.  Here, the temperature 
analysis would need to be determined first to examine which pyromarkers are produced and 
most abundant between various smoking methods of FTPs.  Temperature variance between 
methods of smoking drugs may lead to the production of different pyromarkers.  Smoking 
methods can result in different temperature ramping rate and peak temperatures and 
therefore, a smoking method with higher peak temperature will further degrade pyromarkers 
than a lower temperature smoking method.  As a result, this can produce adversely different 
effects in drug abuser since the dominant or more pronounced pyromarkers would change as 
a result of different smoking method used.  
It is shown by Baker that the highest solid phase temperatures of ~900 ºC, occurs in 
the periphery of the coal, whilst the gas phase temperature in the same region is 605-770 ºC.  
Also, fentanyl smoking methods do not have a well defined/designed coal zone for 
smoldering like manufactured tobacco cigarettes.  If fentanyl were to be smoked like a 
cigarette it would be hand-rolled and not uniform.  One obvious difference in their burning 
characteristics is that hand-rolled cigarettes tend to go out unless puffed by the smoker, 
whereas a cigarette with tightly packed tobacco will smolders for about twenty minutes with 
no assistance from the smoker.109  In most cases, drug abusers want to extinguish the burning 
of the drugs so as not to waste anything before the next hit.  Also, it has been reported that 
the temperatures reached from “chasing the dragon” with heroin were between 200 ºC and 
300 ºC, which is much lower than the tobacco cigarette studies.110   
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In the past, a number of temperature measurement methods have been used to 
determine the temperature distribution of tobacco cigarettes.  These include thermocouples 
inserted into the cigarette, optical pyrometry, infrared photometry, and X-ray scanning of 
beads embedded in the tobacco, which melt at various temperatures.95  Temperature 
distribution detection methods will be modeled on those described by Baker.  In the analysis 
of tobacco cigarette temperature distribution, Baker employed two different methods of 
measurements, one for the solid phase (infrared system) and one for the gas phase 
(thermocouple system), and his results are generally accepted as being representative of the 
temperatures encountered inside a burning cigarette.111  Although Laszlo et al. criticized that 
the thermocouple measurements for the solid phase inside a cigarette coal was inaccurate due 
to the poor thermal contact between the thermocouple junction and tobacco strands, Baker 
proved its insignificance.112  The authors showed that occasionally (< 1%) one of the 
replicates values would be significantly different from the mean.  This was presumably 
caused by an abnormal strand-junction contact, the thermocouple indicating a temperature 
dependence on both the gas and solid phases.112 
Here a method was developed to determine the maximum temperature achieved and 
the rate of temperature increase by smoking FTPs using the common method of “chasing the 
dragon.”  Bare thermocouple sensors were used for temperature analysis in a setup is 
furthered explained in this chapter.  A box fabricated with Lexan® with an open top was 
constructed to shield airflow whilst under the fume hood.  At the time of analysis, reservoir 
FTPs (Figure 1-1A) had entirely phased out of the pharmaceutical market due to the misuse 
and only matrix FTPs (Figure 1-1B) were available.  
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3.2.0 Materials and Methods 
 
Duragesic® 100 mcg/h fentanyl transdermal system patches were obtained from 
McKesson (San Francisco, CA, USA).  HPLC grade methanol was purchased from Fisher 
Science (Fair Lawn, NJ, USA). 
3.2.1 Thermocouple 
 
Temperature analysis was performed using a Type K, CHAL-010 thermocouple 
(Omega, Inc., Stamford, CT, USA).  The Type K unsheathed fine gage thermocouples were 
0.25 mm in diameter and 24 inches in length.  The thermocouple sensors were composed 
solely of a Chromega® (nickel-Chromium) positive leg and an Alomega® (nickel-
aluminum) negative leg that are beaded to create the thermocouple circuit.  SMPW glass 
filled nylon Type K miniature connectors were used to connect the thermocouple sensors to 
the Datalogger.  Temperature range for Type K alloys is -270 to 1372 °C.81  
A HH506RA Dual Input, High Accuracy Datalogger/Thermometer with NIST 
traceable calibration with points was used (Omega, Inc., Stamford, CT, USA).  The 
datalogger is a portable digital thermometer that can measure K, J, S, T, E, and N 
thermocouples with real-time data and data logging capabilities.  A RS-232 cable was 
installed to connect the datalogger to the computer com port.  Data acquisition was set to 
record the temperatures of the two thermocouples at 1 °C/s using the HH506RA software 
provided.   Data obtained were in seconds for the time, temperature in Celsius for both T1 
and T2, as well the as the temperature difference between T1 and T2 was recorded on the 
computer software.  Data is then exported to Microsoft Excel worksheet.   
3.2.2 Setup Diagram 
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Due to safety hazards associated with burning FTPs, the apparatus was position under 
a fume hood.  A barrier was constructed to shield airflow from the fume hood so that the 
butane lighter could produce a steady laminar flame.  Using Lexan®, a four-sided box 
shaped barrier was constructed according to the sketch show as Figure 3-1.  Slip-over panel 
piano hinges made of a polyvinyl carbon and polyester were used for ease of construction 
and manipulation.    
This box here contained a ring stand to hold the FTP sample on single layer of typical 
household aluminum foil and a sliding butane flame platform.  Holes in the box were 
arranged so that the thermocouple sensors could go into the box and that the butane flame 




Figure 3-1.  Schematic of box set up with A) front angle view, B) front view, C) left view 
and D) right view. 
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The sample was heated in single layer of typical aluminum foil that was cut in a circle 
with a diameter of 6.5 cm and placed on a 6 cm in diameter ring on a stand.  Due to safety 
features and the constant need for pressure to depress the gas release valve on typical 
cigarette lighters, a Microflame Torch Model B with only butane gas was used.  A relaxed 
laminar flame allowed for an accurate simulation for the street practice of smoking FTPs by 
means of  “chasing the dragon.”  The tip of the flame was centered in the middle of the foil 
and was approximately 0.8 cm away from the underneath of the foil (Figure 3-2).  The exact 
location of the flame was fixed as much as possible to eliminate variables of the analysis.   
The pieces of the FTP were cut in 1.0 cm in width and 3.6 cm in length.  The FTP 
piece was folded over thermocouple in channel port 1 on the datalogger (T1) and sandwiched 
in the middle of the FTP sample (Figure 3-3).  The thermocouple in channel port 2 on the 
data logger (T2) rested on the very top of the sandwiched piece of FTP (Figure 3-3).  Glass 
rods, electrical tape, and custom made glass rod holders were used to help position the 
thermocouple sensors accordingly. 
For each FTP sample analysis the following events occurred:  The butane release 
valve was rotated and a flint striker was used to create the spark to ignition.  The butane 
lighter was then positioned on the platform within the designated markers.  The door to the 
Lexan® box was closed and the fume hood sash was lowered.  Data acquisition by the 
computer software was initiated and the flame was introduced by sliding the butane flame 
platform within the designated marking to insure fixed positioning after repeated runs.  Once 
smoke was observed visually, the flame remained positioned for 10 s.  After 10 s elapsed, the 
flame was removed by sliding the butane lighter platform back to its original location.  Data 
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collection on the software remained approximately 30 s after flame was removed from the 
FTPs.  Data from the software was then exported to Microsoft Excel worksheets.   
Due to the cost of FTPs, the process was developed and optimized using typical 
office tape to mimic the FTPs.  Here the markers for positioning were affixed into position 









Figure 3-2.  “Chasing the dragon” temperature analysis setup inside the smoking box 






Figure 3-3.  Close-up view of the T1 sandwiched in the middle and T2 rested on the top 
of the FTP sample on the foil. 
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3.3.0 Results and Discussion 
The temperature results of the 16 trials in regards to the moment smoke was visually 
observed, maximum temperature obtained while burning, and the rate of temperature 
increase is summarized in Table 3-1.  The full results of each trial run are located in 
Appendix A, where the asterisked denotes trial where the setup failed where the 
thermocouple sensors fell out of place during the burning process.  The smoke temperature is 
the temperature at which smoke was visually observed emanating from the sample.  These 
values were not consistent between trials as noted in Appendix A.  This is most likely due to 
the fact that the heating of the FTP was not evenly distributed which is expected with the 
smoking method being studied.  This factor is not critical in the scope of the present analysis; 
rather, determining the range of temperatures observed was crucial.  Using this method, the 
maximum recorded temperature was 315.1 °C.  This temperature is in rough agreement with 
that report for the heroin studies, but significantly lower for other fentanyl studies mentioned 
earlier. 
The maximum temperature is the highest temperature obtained in the smoking 
process.  This temperature was of importance in this study since the values used in Chapter 2 
were of temperatures obtained in manufactured tobacco cigarettes.  The temperature under 
cigarette smoldering conditions was hypothesized to be high relative to “chasing the dragon”.  
The temperatures recorded ranged from 214.1 - 441.6 °C, with most trials being between 250 
°C and 300 °C (failed trials omitted).   
The rate of temperature increase was assessed by the starting recorded room 
temperature of the FTPs to the maximum temperature obtained by the FTPs by heating.  The 
rates were given as °C/s.  These values ranged from 8.3 °C/s to 23.0 °C/s, with most of the 
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recorded values being around 20 °C/s.  This value is the same rate of increase as the one used 
in the previous pyrolysis study in Chapter 2.  
Figure 3-4 is a plot of T1 and T2 over time for Trial 8 analysis.  This is just one 
example of the general trend of the temperature increase of each of the thermocouples.  In 
this specific trial, it is observed that T1 has a faster rate of temperature increase and has a 
higher maximum temperature.  In general, the trends vary slightly between trials, however, 
this is also not a critical factor of the overall scope of the analysis.  
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Table 3-1.  Temperature data of smoking FTPs using the “chasing the dragon” method. 
 
Smoke Observed Temp. Max. Temp. Rate Increase 
 
T1 (°C) T2 (°C) T1 (°C) T2 (°C) T1 (°C/s) T2 (°C/s) 
Max 315.1 308.6 441.6 397.7 28.0 24.9 










































 The temperature analysis was essential for determining realistic temperature 
estimations obtained during smoking of the FTPs by means of the “chasing the dragon” 
method.  This experimentation allowed for a more accurate determination of parameters 
settings for the Py-GC/MS analysis of fentanyl rather than basing the parameters on 
manufactured tobacco cigarettes studies.  Here it is noted that temperatures never exceeded 
450 °C at either the smoke temperature or the maximum temperature readings.  This is well 
below the 750 °C pyrolysis temperature used in Chapter 2 that was again based on 
manufactured tobacco cigarettes.  The rate of temperature increase was approximately 20 
°C/s for most of the trial runs in the experiment.  Data obtained indicates that manufactured 
tobacco cigarette temperature is not applicable here under.  The knowledge gained here will 
help determine if at lower temperatures different pyromarkers are present or even different 
pyromarkers is most dominant besides propionanilide noted in Chapter 2.  The temperature 
parameters determined here is applied to the Py-GC/MS for the analysis of pyromarkers in 

















Chapter 4: Application of Temperatures 
Characteristics Obtained from Smoking FTPs By 






This chapter reflects the pyrolysis parameters that were obtained in the previous 
chapter that used thermocouples for temperatures analysis on smoking FTPs by means of the 
“chasing the dragon” method.  The results from Chapter 3 indicated that the temperatures 
obtained by smoking FTPs by means of "chasing the dragon" did not reach to the 750 °C 
temperatures that were used in the previous study.  Although 450 °C is the maximum 
temperature observed in the thermocouple temperature study, these lower increments of 
temperature were evaluated to see if 50 °C temperature variations made any differences.  
As stated previously, Manral et al. analyzed the pyrolysis of fentanyl from 
temperature of 250 to 900 °C using a large sample size of 50 mg.102  It has long been 
recognized that small samples, typically less than 1 mg, good heat transfer and rapid heating 
of the pyrolysis element are essential in achieving reproducibility.89,113  The smaller the 
sample size, the more likely it is to pyrolyze in a uniform and reproducible way by having all 
of the sample material in close contact with the pyrolyzer to experience the same temperature 
at the same time.83,90   
Manral et al., also found only fentanyl and no pyromarkers observed up to 350 °C, 
therefore concluding that fentanyl was stable up to 350 °C.  At 500 °C, propionanilide and 
PEP were the only pyromarkers observed.  With this, the authors concluded that higher 
temperatures of 750 °C resulted in extensive degradation of not only the parent fentanyl 
compound itself, but also of the propionanilide and PEP.  Manral et al. pyrolyzed 
propionanilide and PEP at 750 °C and determined 3-methylindone and phenylisocyanate as a 
result of intramolecular rearrangements (Figure 2-4).102  As stated before, the authors 
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ascertained that phenylisocyanate may lead to the formation of hydrogen cyanide, which 
would be a large factor in the toxicity of smoked fentanyl.102    
Data from this project does not support the idea that fentanyl is stable up to 350  °C 
as stated by Manral et al. and is evaluated at lower temperatures.  Here six temperatures of 
were evaluated from 200 to 450 °C in 50 °C increments on the Py-GC/MS.  This is to 
observe any differences seen in regards to unique or prevalent pyromarkers present in the 
smoking process in comparison to the higher pyrolysis temperature previously studied.   
 
4.2.0 Materials and Methods 
Fentanyl and norfentanyl oxalate, both in methanol solvent were obtained from 
Cerilliant Corporation (Round Rock, TX, USA).  Despropionyl fentanyl was purchased from 
Biomol (Plymouth Meeting, PA, USA). Duragesic® 100 mcg/h fentanyl transdermal system 
patches were obtained from McKesson (San Francisco, CA, USA). Pyridine, benzaldehyde, 
phenylacetaldehyde, propionanilide, and HPLC grade methanol were purchased from Sigma 
Aldrich (St. Louis, MO, USA). 
4.2.1 Py-GC/MS 
 
Here the same CDS Analytical 5200 Pyroprobe was used in trapping mode to 
pyrolyze the samples under aerobic conditions using air and a full 20:35 mesh Tenax-TA 
sorbent tube trap (CDS Analytical, Inc., Oxford, PA).  However, instead of the Perkin Elmer 
GC/MS, a Shimadzu GC/MS QP2010S was used (Shimadzu Corporation, Kyoto, Japan).  
The GC was equipped with an Rxi®-5Sil MS with Integra-Guard® (30 m, 0.25 mm i.d., 0.50 
μm film thickness, Restek, Bellefonte, PA, USA).  The MS was equipped with an electron 
ionization source and quadrupole mass analyzer with a scanning range of m/z 50–600.  The 
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interface and ion source temperatures were 300 °C and 250 °C, respectively.  GC/MS 
parameters were slightly altered from previous analysis with a lower final GC oven 
temperature to minimize the capillary column bleeding and prolong the life of the column 
(Table 4-1). 
The components and workings of the CDS analytical pyroprobe unit were explained 
previously in Section 2.2.1.  Analysis was done only in aerobic conditions where air was 
used as the reactant gas and helium was used as the carrier gas.  Table 4-1 lists the 
parameters for the Py-GC/MS at the 6 different pyrolysis temperatures for both the fentanyl 
standards and the FTPs.  All samples were run in triplicate to determine repeatability of the 
method, at least qualitatively. With the sorbent tube trap, the desorb temperature is necessary 
to desorb the collected analytes and transfer them to the GC at the beginning of the run.  In 
addition, a 250 ˚C desorption temperature was assessed in the 200 ˚C pyrolysis analysis run.  
This is to observe any pyromarkers that were not able to desorb at 200 °C.   
 With a quartz tube filled with a plug of quartz wool inside the filament of the 
pyrolysis probe, 10 μg of the fentanyl solution was deposited using a microliter syringe.  The 
fentanyl in methanol solution was a concentration of 1000 ppm.  The sample was then dried 
to remove some of the excess solvent by heating the filament to 50 °C for 30 s.  The probe 





Table 4-1.  Py-GC/MS parameters for the pyrolysis of fentanyl standards and FTPs.  
Pyroprobe Conditions 200 °C 200 °C w/ 250 °C desorb 250 °C 300 °C 350 °C 400 °C 450 °C 
          
Pyroprobe Temperatures        
Initial 50 °C, 1 s 50 °C, 1 s 50 °C, 1 s 50 °C, 1 s 50 °C, 1 s 50 °C, 1 s 50 °C, 1 s 
Ramp Rate 20 °C/s 20 °C/s 20 °C/s 20 °C/s 20 °C/s 20 °C/s 20 °C/s 
Final 200 °C, 10 s 200 °C, 10 s 250 °C, 10 s 300 °C, 10 s 350 °C, 10 s 400 °C, 10 s 450 °C, 10 s 
Accessory Parameters         
Rest 50 °C 50 °C 50 °C 50 °C 50 °C 50 °C 50 °C 
Initial 50 °C, 1 min 50 °C, 1 min 50 °C, 1 min 50 °C, 1 min 50 °C, 1 min 50 °C, 1 min 50 °C, 1 min 
Ramp Rate 100 °C/min 100 °C/min 100 °C/min 100 °C/min 100 °C/min 100 °C/min 100 °C/min 
Final 200 °C, 5 min 200 °C, 5 min 250 °C, 5 min 300 °C, 5 min 300 °C, 5 min 300 °C, 5 min 300 °C, 5 min 
Trap Temperatures         
Reactant Gas 6.50 min 6.50 min 7.00 min 7.50 min 7.50 min 7.50 min 7.50 min 
Rest 50 °C 50 °C 50 °C 50 °C 50 °C 50 °C 50 °C 
Desorb 200 °C, 2 min 250 °C, 2 min 250 °C, 2 min 300 °C, 2 min 300 °C, 2 min 300 °C, 2 min 300 °C, 2 min 
Iso Zones         
Transfer Line 200  °C 250  °C 250  °C 300  °C 300  °C 300  °C 300  °C 
Valve Oven 200  °C 250  °C 250  °C 300  °C 300  °C 300  °C 300  °C 
          
GC Conditions 
Injector Port 200 °C 250 °C 250 °C 300 °C 300 °C 300 °C 300 °C 
Initial 70 °C 70 °C 70 °C 70 °C 70 °C 70 °C 70 °C 
Ramp Rate 15 °C/min 15 °C/min 15 °C/min 15 °C/min 15 °C/min 15 °C/min 15 °C/min 
Final 300 °C, 4.67 min  300 °C, 4.67 min  300 °C, 4.67 min  300 °C, 4.67 min  300 °C, 4.67 min  300 °C, 4.67 min  300 °C, 4.67 min  
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 For the FTPs, the backings were removed and the entire patch was folded over on 
itself on the adhesive side for ease of handling.  Then small pieces of approximately 1 mm by 
1 mm were cut resulting to a weight ranging from 200-300 µg.  Each piece was then 
sandwiched between two plugs of quartz wool in the quartz sample tube.  The sample tube 
was then inserted in the coiled filament of the probe and successively into the pyroprobe unit 
for pyrolysis under the set conditions.  
 
 
4.3.0 Results and Discussion 
 
 The pyromarkers of the fentanyl standard and the FTPs listed in Table 4-2 and 4-3.  
Appendix B includes results of all pyromarkers observed for each trial run.  These 
pyromarkers were initially identified using NIST MS library.  Identification was confirmed 
by analysis of SRMs by the comparison of retention times and mass spectra for the following 
analytes: pyridine, benzaldehyde, phenylacetaldehye, propionanilide, norfentanyl, 
despropionyl fentanyl, and fentanyl.  The other pyromarkers observed were considered to be 
tentatively identified based solely by the NIST MS database.  The percent areas of each 
pyromarker were normalized relative to the largest peak area in the chromatogram.   
4.3.1 Pyromarkers of Fentanyl Standard 
 
It is shown here that propionanilide is observed under all pyrolysis temperature 
conditions with the highest peak area, as low at 200 ˚C, for the pyrolysis of the fentanyl 
standard (Table 4-2).  This indicates that fentanyl itself is not stable below 350 ˚C as found in 
literature and hence is not likely suitable for volatilization for inhalation administration as 
sought by Manral et al.  At 200 ˚C, only pyridine and fentanyl was observed; however, with 
250 ˚C for in desorption temperature, styrene, benzaldehyde, aniline, phenylacetaldehyde, 
 
 86 
and propionanilide was observed in addition.  This increase in 50 ˚C in temperature was 
necessary of these pyromarkers to desorb off of the Tenax-TA trap.   
Since fentanyl HCl was not used in this analysis due to availability, chlorinated 
pyromarkers were not observed as seen for the pyrolysis at 750 ˚C in aerobic conditions 
(Table 2-2).  The only pyromarker other than the chlorinated ones observed at 750 ˚C and not 
here under any of these temperatures was despropionyl fentanyl.  This may have been due the 
smaller sample size used here in comparison to the previous studies where 50-100 μg of solid 
fentanyl HCl were used. Overall, pyridine, styrene, benzaldehyde, aniline, 
phenylacetaldehyde, propionanilide, and fentanyl were consistently detected at all six 
temperatures of pyrolysis.   
The pyrolytic degradation pathways of pyridine, styrene, benzaldehyde, aniline, 
phenylacetaldehyde, and propionanilide likely underwent the same reactions as explained in 
section 2.3.1.  The only difference observed was 3-methyl-pyridine at 450 °C.  The formation 
of this product is not well understood.  It is the likelihood that the piperidine ring free radical 
allows for dehydrogenation for the pyridine ring and sigmatropic rearrangement for a 1,5-






Table 4-2.  Pyromarkers of the pyrolysis of the fentanyl standard. 
      250 ˚C desorb             
200 ˚C % Area % Area 250 ˚C  % Area 300 ˚C  % Area 
1. Pyridine 
 
24.0 1. Pyridine 20.8 1. Pyridine 56.5 
2. Styrene 
 
20.0 2. Styrene 21.8 2. Styrene 47.2 
3. Benzaldehyde 
 
12.2 3. Benzaldehyde 8.3 3. Benzaldehyde 26.5 
4. Aniline 
 
3.8 4. Aniline 1.0 4. Aniline 2.9 
5. Phenylacetaldehyde 
 
2.9 5. Phenylacetaldehyde 3.3 5. Phenylacetaldehyde 8.9 
1,6. Propionanilide 100 100 6. Propionanilide 100 6. Propionanilide 100 
2,7. Fentanyl 8.2 3.1 7. Fentanyl 12.4 7. Fentanyl 63.2 
  
   
            
350 ˚C  % Area   400 ˚C  % Area 450 ˚C  % Area 
1. Pyridine 58.5 
 
1. Pyridine 46.2 1. Pyridine 42.2 
2. Styrene 47.1 
 
2. Styrene 38.6 2. 3-Methyl-pyridine 1.1 
3. Benzaldehyde 24.5 
 
3. Benzaldehyde 20.2 3. Styrene 32.3 
4. Aniline 2.5 
 
4. Aniline 1.5 4. Benzaldehyde 21.1 
5. Phenylacetaldehyde 7.8 
 
5. Phenylacetaldehyde 6.3 5. Aniline 3.8 
6. Propionanilide 100 
 
6. Propionanilide 100 6. Phenylacetaldehyde 4.3 
7. Fentanyl 42.1 
 
7. Fentanyl 65.5 7. Propionanilide 100 
              8. Fentanyl 24.6 
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Figure 4-2 shows the comparison of the GC chromatograms of the pyrolysis of the 
fentanyl standard under all pyrolysis temperature conditions.  The chromatographic peaks 
labeled with numbers corresponding to their identification listed on Table 4-2.  Peaks that are 
not labeled could not be identified using the NIST MS database.  It is seen here that the 
chromatography pattern is similar and is observed at all three trials at each temperature 
condition.   
There is a noticeable difference in comparison of the GC chromatograms of 200 °C with 
200 °C (Figure 4-1A) and 250 °C (Figure 4-1B) for desorption of pyromarkers off the Tenax- 
TA trap to the GC/MS for analysis.  In all instances, propionanilide is observed with the 
highest peak area, as well as peak intensity, at RT ~9.329 min.  As the temperature of 










































































4.3.2 Pyromarkers of FTPs  
 
The pyromarkers observed under all temperature conditions for the pyrolysis of the FTPs 
are located in Table 4-3.  The analytes reported in this table were observed consistently in all 
triplicate analyses.  All observed pyromarkers, including those that were detected in all three 
replicates, for each trial run are located in Appendix B.  The same pyromarkers observed for the 
pyrolysis of fentanyl standard under all six temperature conditions were detected in the pyrolysis 
of the FTPs at the under the same conditions with the exception of aniline.  Aniline contained the 
lowest percent area for the fentanyl standard, and thus, not surprising that aniline is not observed 
in the pyrolysis of the FTPs.  
 Additional pyromarkers observed besides those see in Table 4-2 can be attributed to the 
other unknown material that is incorporated into the manufacturing of the FTPs.  Again, these 
materials include plasticizers and adhesives to allow the patch to adhere to the skin of patients 
for dermal absorption.  At the pyrolysis of 200 °C, both of the desorbing temperatures produced 
the same pyromarkers.  This is likely due to the increase in sample size of the FTP in comparison 
to the fentanyl standard sample size deposited on the quartz wool. 
 It can be noted that from 200 °C to 300 °C, propionanilide has the greatest peak area.  At 
300 °C, 2-ethyl-1-hexanol (2-EH) increases in peak area until 400 ºC, where it surpasses the 
peak area of propionanilide.  2-EH is considered to be not acutely toxic in regards to inhalation 
in rat studies and is a synthetic alcohol that is mainly used in the manufacture of ester plasticizer 
primarily to used in produce soft polyvinyl chloride.114  Although it is commonly found in the 





Table 4-3.  Pyromarkers of FTPs from 200-450 ˚C. 
      250 ˚C desorb             
200 ˚C % Area % Area 250 ˚C  % Area 300 ˚C  % Area 
1. Pyridine 21.9 14.6 1. Pyridine 27.6 1. Pyridine 30.5 
2. Styrene 25.9 23.0 2. Styrene 33.1 2. 3-Methylene-heptane 41.1 
3. Benzaldehyde 11.8 8.0 3. Benzaldehyde 17.4 3. 3-Heptanone 7.8 
4. Phenylacetaldehyde 9.1 7.2 4. Aniline 2.2 4. Styrene 31.6 
5. Propionanilide 100 100 5. 3-Pyridinecarboxaldehyde 1.1 5. 2-Ethyl-2-hexenal 2.1 
6. Fentanyl 2.0 16.2 6. Benzyl Alcohol 0.7 6. 2-Ethyl-hexanal 15.1 
  
  
  7. Phenylacetaldehyde 7.3 7. Benzaldehyde 26.5 
  
  
  8. 1-Phenyl-1,2-propanedione 1.5 8. 2-EH 57.7 
  
  
  9. Benzenecarboxylic acid 1.2 9. Phenylacetaldehyde 10.1 
  
  
  10. Propionanilide 100 10. 1-Phenyl-1,2-propanedione 2.0 
  
  
  11. N-(2-phenylethyl)-formamide 2.0 11. 2-Ethylhexyl ester acetic acid  1.2 
  
  




   




   




   




   
16. 2-EEFA 2.3 








Table 4-3.  Continued.  
350 ˚C  % Area 400 ˚C  % Area 450 ˚C  % Area 
1. Pyridine 32.0 1. Pyridine 23.2 1. Pyridine 23.5 
2. 3-Methylene-heptane 36.1 2. 3-Methylene-heptane 50.0 2. 3-Methylene-heptane 65.9 
3. 3-Heptanone 5.1 3. 3-Heptanone 5.6 3. 3-Heptanone 7.9 
4. Styrene 34.2 4. Styrene 17.8 4. Styrene 13.5 
5. 2-Ethyl-hexanal 10.8 5. 2-Ethyl-2-hexenal 3.2 5. 2-Ethyl-hexanal 12.6 
6. Benzaldehyde 27.6 6. 2-Ethyl-hexanal 13.6 6. Benzaldehyde 26.1 
7. 2-EH 55.8 7. Benzaldehyde 21.1 7. 2-EH 100 
8. Benzyl Alcohol 1.8 8. 2-EH 100 8. Phenylacetaldehyde 4.2 
9. Phenylacetaldehyde 8.3 9. Phenylacetaldehyde 5.0 9. 2-Ethylhexyl ester acetic acid 4.3 
10. 2-Ethylhexyl ester acetic acid  1.1 10. 2-Ethylhexyl ester acetic acid 1.8 10. Benzenecarboxylic acid 3.4 
11. Benzenecarboxylic acid 2.8 11. Benzenecarboxylic acid 2.7 11. 2-Ethylhexyl ester 2-propenoic acid 27.9 
12. 2-Ethylhexyl ester 2-propenoic acid 4.8 12. 2-Ethylhexyl ester 2-propenoic acid 13.1 12. 2-Ethylhexyl methacrylate 3.1 
13. Propionanilide 100 13. 2-Ethylhexyl methacrylate 1.6 13. n-Butyric acid 2-ethylhexyl ester 1.3 
14. 2-EEFA 2.1 14. 2-EECA 1.8 14. 2-EECA 2.7 
15. Fentanyl 1.7 15. Propionanilide 69.1 15. Propionanilide 63.0 
  
 
  16. 2-Ethylhexyl ester pentanoic acid 3.8 16. 2-Ethylhexyl ester pentanoic acid 5.2 
  
 
  17. 2-EEFA 3.8 17. 2-EEFA 1.9 





Figure 4-3 shows all the GC chromatograms of the pyrolysis of the FTPs under all pyrolytic 
temperature conditions.  The peaks are labeled with numbers that coincide with the pyromarkers 
listed in Table 4-3.  Peaks that were not labeled could not be identified through the NIST MS 
database.  Again, most of these unidentifiable peaks were likely pyromarkers of the plasticizers 
of the FTPs since they are not observed in the fentanyl standard alone.  For the 200 °C, both 
desorbing temperatures resulted in similar pyromarkers with higher peak intensity and areas for 
250 °C (Figure 4-3A) than 200 °C (Figure 4-3B).  Again, this higher temperature afforded more 
of the pyromarkers to desorb off of the Tenax-TA in the trap.   
In Figure 4-3C, there is a magnified view of the chromatographic peaks for enhance 
viewing purposes.  The pattern of the chromatograms is similar with greater intensity as the 
pyrolytic temperature increases.  The increase in pyrolytic temperature produces an increase in 
number of peaks; however, most of those peaks were unidentifiable using the NIST MS 
database.  At 350 °C and below, propionanilide dominates as having the largest peak area.  Not 
until 400 °C and above, does 2-EH has the largest peak area and intensity in the chromatograms 
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 Overall, pyridine, styrene, benzaldehyde, phenylacetaldehyde, propionanilide, and 
fentanyl were consistently detected at all six temperatures of pyrolysis of both the fentanyl 
standard and the FTPs.  These pyromarkers seen here were similar to that of the results under 
the pyrolytic conditions of 750 ºC in section 2.  Propionanilide has shown to have the highest 
peak area for both fentanyl standard and FTPs at all pyrolytic temperatures with exception to 
400 °C and 450 °C for the FTPs analysis.  At those temperature 2-EH increases to obtain the 
highest peak area and intensity.  Although this plasticizer can be commonly found in the 
environment, it has the potential to be an additional marker for investigative purposes to link 
those who have smoked FTPs as mean of ingestion.   
The increase in pyrolytic temperature for both the pyrolysis of the fentanyl standard and 
the FTPs increase the intensity of the pyromarkers detected.  This increase in temperature has 
also allowed more chromatographic peak for the FTPs that were likely the inclusion of 
plasticizers, adhesives, and other materials that are incorporated into the manufacturing of the 
FTPs by the pharmaceutical company.  Lastly, even as low as 200 ºC for a pyrolytic 
temperature fentanyl is shown to degrade through elimination reaction to propionanilide.  
This clearly disputes the previously discussed literature references that stated fentanyl was 
stable up to 350 °C.  


























Illicit drugs commonly contain other substances in addition to the active ingredient, 
which can have serious adverse health consequences or even cause premature death.  In 
general, an “adulterant” typically refers to the pharmacologically active ingredients; 
“contaminant” refers to the by-products of the manufacturing process, and the “diluent” 
refers to inert substances.115  However, many have generalized the categories previously 
mentioned as adulterants.  It has been seen that the adulterants used by drug dealers, drug 
users, and the general public include but not limited to mannitol, sugars, gravy powder, 
chalk, codeine, rat poison, ground glass, household cleaning products, and brick dust.115  
Multiple combinations and variations of adulterants have been in illicit street samples of 
heroin.  Some of the many reasons for the use of these adulterants in illicit drugs include to 
bulk, dilute, complement or even to enhance the effects of the drugs itself.115  Other 
explanations allude to unintentional addition as a result of manufacturing, productions, or 
storage techniques.  
The quality assurance, sterile production, and accurate dosage administration cannot 
be upheld in the illicit manufacture in which drug sellers and users can only make inadequate 
assessments of the quality, purity, and chemical composition of any of the drugs they buy, 
sell, or use.116  Cases seen in recent years of heroin laced with fentanyl seem to enhance or 
mimic the illicit drug effects, either to give the impression of a better quality or mask the 
poor quality of the heroin obtained.  This has been seen in other drugs, for examples: 
procaine and lidocaine have similar anaesthetic properties to cocaine; phenacetin has similar 
physical properties to cocaine; acetominophen has similar bitter taste to (white) heroin; 




similar (but milder) stimulant properties to cocaine, amphetamine, and ecstasy.115 Again, as 
mentioned earlier, caffeine in heroin has been observed to facilitate in volatilization of 
heroin.  
As mentioned previously, near the end of 2005 and early into 2006, the government 
and media reported an increase in the number of individuals who have overdosed on heroin 
laced with fentanyl as a diluent.  This fentanyl-laced heroin was a means of making up for 
the poor quality heroin.  Given its toxicity drug dealers have trouble adjusting pure fentanyl 
into proper dosage concentrations.  As a result, heroin users who knowingly or unknowingly 
use the substance containing fentanyl have difficulty determining how much to take to get 
their “high” and can mistakenly take lethal quantities of fentanyl.36  Only a slight excess in 
the amount of fentanyl taken can be, and is often, fatal because the resulting level of 
respiratory depression is sufficient to cause the user to stop breathing.36,63,66  As previously 
noted, the pyromarkers of heroin are known.  However, the combination of fentanyl and 
heroin pyromarkers has not been studied and is evaluated here.  It was suspected that the 
pyrolysis of the combination of two different drugs had the potential to produce different 
pyromarkers not observed by pyrolysis as separate entities.  This has been seen by the 
pyrolysis of methamphetamine mixed with tobacco.117,118  
Heroin base is preferred to heroin HCl, since the bases has a lower melting point of 
173 °C than the HCl salt of 243-244 °C and because of its relative insensitivity to 
degradation.66,119  However, due to the availability, high cost, and time to obtain heroin base, 
heroin HCl was used here for analysis instead.  Cook and Brine had observed heroin 





5.2.0 Materials and Methods 
 
Fentanyl and 6-MAM standards were obtained from Cerilliant Corporation (Round 
Rock, TX, USA) and Sigma Aldrich (St. Louis, MO, USA).  Heroin HCl standards were 
obtained from Sigma-Aldrich (St. Louis, MO, USA).  HPLC grade methanol was purchased 
from Fisher Science (Fair Lawn, NJ, USA). 
5.2.1 Py-GC/MS 
 
The CDS Analytical 5200 Pyroprobe was used in trapping mode to pyrolyze the 
samples under aerobic conditions using air and a full 20:35 mesh Tenax-TA sorbent tube trap 
(CDS Analytical, Inc., Oxford, PA, USA).  The pyrolysis unit was interfaced the Shimadzu 
GC/MS QP2010S.  The GC was equipped with an Rxi®-5Sil MS with Integra-Guard® (30 
m, 0.25 mm i.d., 0.50 μm film thickness, Restek, Bellefonte, PA).  The MS was equipped 
with an electron ionization source and quadrupole mass analyzer with a scanning range of 
m/z 50–600.  The interface and ion source temperatures were 300 °C and 250 °C, 
respectively. 
Analysis was done only in aerobic conditions where air was used as the reactant gas 
and helium was used as the carrier gas.  All samples were run in triplicate for repeatability of 
method analysis.  Table 5-1 lists the parameters for the Py-GC/MS at the 6 different pyrolysis 
temperatures for both the heroin standards and the heroin and fentanyl mixes.  With the 
sorbent tube trap, a desorption temperature is necessary to desorb the collected analytes and 
transfer them to the GC at the beginning of the run.  In addition, a 300 ˚C desorption 
temperature was determined to be necessary for to desorb the pyromarkers at 200 ˚C and 250 




 A sample of 1000 ppm solution was made for the pyrolysis of heroin alone.  The 10 
μg sample was deposited on a plug of quartz wool in the sample tube.  In addition, three 
different samples mixes of heroin and fentanyl were prepared in ratios of 3:1, 1:1, and 1:3.  
Each sample mix was made from 1000 ppm stock solution of heroin and fentanyl.  With a 
quartz tube filled with a plug of quartz wool inside the filament of the pyrolysis probe, 10 μL 
of the mixed solution was deposited using a microliter syringe.  The sample was then dried to 
remove some of the excess solvent by heating the filament to 50 °C for 30 s.  The probe was 





Table 5-1.  Py-GC/MS parameters for the pyrolysis of heroin standards and mixes. 
Pyroprobe Conditions 200 °C 250 °C 300 °C 350 °C 400 °C 450 °C 
         
Pyroprobe Temperatures       
Initial 50 °C, 1 s 50 °C, 1 s 50 °C, 1 s 50 °C, 1 s 50 °C, 1 s 50 °C, 1 s 
Ramp Rate 20 °C/s 20 °C/s 20 °C/s 20 °C/s 20 °C/s 20 °C/s 
Final 200 °C, 10 s 250 °C, 10 s 300 °C, 10 s 350 °C, 10 s 400 °C, 10 s 450 °C, 10 s 
Accessory Parameters        
Rest 50 °C 50 °C 50 °C 50 °C 50 °C 50 °C 
Initial 50 °C, 1 min 50 °C, 1 min 50 °C, 1 min 50 °C, 1 min 50 °C, 1 min 50 °C, 1 min 
Ramp Rate 100 °C/min 100 °C/min 100 °C/min 100 °C/min 100 °C/min 100 °C/min 
Final 200 °C, 5 min 250 °C, 5 min 300 °C, 5 min 300 °C, 5 min 300 °C, 5 min 300 °C, 5 min 
Trap Temperatures        
Reactant Gas 6.50 min 7.00 min 7.50 min 7.50 min 7.50 min 7.50 min 
Rest 50 °C 50 °C 50 °C 50 °C 50 °C 50 °C 
Desorb 300 °C, 2 min 300 °C, 2 min 300 °C, 2 min 300 °C, 2 min 300 °C, 2 min 300 °C, 2 min 
Iso Zones        
Transfer Line 300  °C 300  °C 300  °C 300  °C 300  °C 300  °C 
Valve Oven 300  °C 300  °C 300  °C 300  °C 300  °C 300  °C 
         
GC Conditions 
Injector Port 300 °C 300 °C 300 °C 300 °C 300 °C 300 °C 
Initial 70 °C 70 °C 70 °C 70 °C 70 °C 70 °C 
Ramp Rate 15 °C/min 15 °C/min 15 °C/min 15 °C/min 15 °C/min 15 °C/min 
Final 300 °C, 4.67 min  300 °C, 4.67 min  300 °C, 4.67 min  300 °C, 4.67 min  300 °C, 4.67 min  300 °C, 4.67 min  
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5.3.0 Results and Discussion 
 
Appendix C contains the chromatograms for the pyrolysis of the heroin standard and the 
results of identified pyromarkers of each of the heroin to fentanyl mixes.  The pyromarkers of 
the heroin standard resulted in 6-MAM and heroin under all pyrolysis parameters.  All 
pyromarkers were initially identified using NIST MS library.  Identification was confirmed 
by analysis of SRMs and the comparison of retention times and mass spectra for the 
following analytes: pyridine, benzaldehyde, phenylacetaldehye, propionanilide, norfentanyl, 
despropionyl fentanyl, fentanyl, 6-MAM, and heroin.  The other pyromarkers observed were 
considered tentatively identified by NIST MS library search.  The percent areas of each 
pyromarker were normalized relative to the largest peak area in the chromatogram.  Under all 
temperature conditions, propionanilide resulted in the largest peak area in the chromatograms 
for both the fentanyl standard and FTPs.   
The pyrolysis of heroin under all conditions resulted in the detection of heroin and 6-
MAM (Appendix C).  Unfortunately, heroin in the HCl salt form has a much higher melting 
point than the base form and did not produce any of the other pyromarkers with this method 
at the analyzed temperature that were previously reported in the literature.  Nonetheless, it 
was interesting to note these results and how it would affect the pyromarkers with the 
addition of fentanyl.   
Table 5-2, 5-3, and 5-4 show the results under all the pyrolytic conditions for the heroin 
to fentanyl mixes of 3:1, 1:1, and 1:3, respectively with a repeatability of n=3.  All 
pyromarkers detected at each trial run as well as GC chromatograms are located in Appendix 
C.  The pyromarkers that were common in all heroin to fentanyl mixes at all pyrolytic 
temperatures were the following: pyridine, styrene, benzaldehyde, phenylacetaldehyde, 
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propionanilide, 6-MAM, heroin, and fentanyl.  Like the pyrolysis of the FTPs, aniline was 
not detected repeatedly in all trial runs. 
5.3.1 Pyromarkers of the Pyrolysis of the 3:1 Heroin to Fentanyl Mix 
For the 3:1 heroin to fentanyl mix, the only differences observed was the detection of 
norfentanyl at 200 °C and acetylbenzoyl at 250 °C (Table 5-2).  It is unclear as to why the 
metabolite norfentanyl is observed here and not at any other pyrolytic temperature or other 
previous chapter.  Also, at a 3:1 ratio, fentanyl is at its lowest concentration for analysis in 
comparison.  The pathway for the formation of acetylbenzoyl is not clear as the formation 
could be likely similar to of phenylacetaldehyde from fentanyl or heroin which is due to the 
elimination reaction producing a free radical with a phenyl ring. The presence of oxygen 
allows the formation of acetylbenzoyl.  This pyromarker has been detected in both the 
pyrolysis of the fentanyl standard and the FTPs; however it was not consistently observed in 
all three replicates (Appendix B). 
5.3.2 Pyromarkers of the Pyrolysis of the 1:1 Heroin to Fentanyl Mix 
 For the 1:1 heroin to fentanyl mix, both norfentanyl and acetylbenzoyl was observed 
at 200 °C (Table 5-3).  At 250 °C, acetylbenzoyl was similarly observed at 250 °C.  In 
addition, at 400 °C, phthalic anhydride is observed.  All other consistant reported 
pyromarkers were the same as mentioned. 
5.3.3 Pyromarkers of the Pyrolysis of the 1:3 Heroin to Fentanyl Mix 
For the 1:3 heroin to fentanyl mix, acetylbenzoyl is observed at 250 °C to 400 °C.  With 
fentanyl having the higher concentration here, it is likely that that the formation of 
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acetylbenzoyl stems from the fentanyl component of the mix.  Norfentanyl is observed at 400 







Table 5-2.  Pyromarkers of the pyrolysis of the 3:1 heroin to fentanyl mix. 
200 ˚C % Area 250 ˚C % Area 300 ˚C % Area 
1. Pyridine 4.7 1. Pyridine 8.1 1. Pyridine 14.1 
2. Styrene 3.6 2. Styrene 5.6 2. Styrene 9.2 
3. Benzaldehyde 1.8 3. Benzaldehyde 3.8 3. Benzaldehyde 5.7 
4. Phenylacetaldehyde 0.8 4. Phenylacetaldehyde 1.0 4. Phenylacetaldehyde 1.4 
5. Propionanilide 29.1 5. Acetylbenzoyl 0.4 5. Propionanilide 31.5 
6. Norfentanyl 0.2 6. Propionanilide 29.1 6. 6-MAM 9.5 
7. 6-MAM 6.2 7. 6-MAM 8.6 7. Heroin 100 
8. Heroin 100 8. Heroin 100 8. Fentanyl 19.0 
9. Fentanyl 21.7 9. Fentanyl 21.8 
  
  
                  
350 ˚C % Area 400 ˚C % Area 450 ˚C % Area 
1. Pyridine 18.3 1. Pyridine 18.7 1. Pyridine 22.1 
2. Styrene 10.5 2. Styrene 12.2 2. Styrene 14.4 
3. Benzaldehyde 8.3 3. Benzaldehyde 7.9 3. Benzaldehyde 7.8 
4. Phenylacetaldehyde 1.8 4. Phenylacetaldehyde 1.7 4. Phenylacetaldehyde 2.3 
5. Propionanilide 37.5 5. Propionanilide 35.4 5. Propionanilide 34.9 
6. 6-MAM 4.0 6. 6-MAM 3.2 6. 6-MAM 17.0 
7. Heroin 100 7. Heroin 100 7. Heroin 100 








Table 5-3.  Pyromarkers of the pyrolysis of the 1:1 heroin to fentanyl mix. 
200 ˚C % Area 250 ˚C  % Area 300 ˚C  % Area 
1. Pyridine 10.3 1. Pyridine 19.4 1. Pyridine 33.6 
2. Styrene 9.1 2. Styrene 14.2 2. Styrene 22.4 
3. Benzaldehyde 3.8 3. Benzaldehyde 7.1 3. Benzaldehyde 14.1 
4. Phenylacetaldehyde 1.9 4. Phenylacetaldehyde 2.7 4. Phenylacetaldehyde 3.9 
5. Acetylbenzoyl 0.5 5. Acetylbenzoyl 0.8 5. Propionanilide 92.5 
6. Propionanilide 64.1 6. Propionanilide 71.5 6. 6-MAM 8.4 
7. Norfentanyl 0.9 7. 6-MAM 8.1 7. Heroin 95.3 
8. 6-MAM 7.5 8. Heroin 92.8 8. Fentanyl 99.2 
9. Heroin 93.7 9. Fentanyl 98.2 
  
  





                  
350 ˚C  % Area 400 ˚C  % Area 450 ˚C  % Area 
1. Pyridine 33.5 1. Pyridine 42.0 1. Pyridine 48.0 
2. Styrene 23.2 2. Styrene 24.8 2. Styrene 35.7 
3. Benzaldehyde 14.0 3. Benzaldehyde 19.2 3. Benzaldehyde 22.0 
4. Phenylacetaldehyde 3.8 4. Phenylacetaldehyde 4.4 4. Phenylacetaldehyde 5.5 
5. Propionanilide 92.9 5. Phthalic anhydride 0.7 5. Propionanilide 69.1 
6. 6-MAM 8.0 6. Propionanilide 100 6. 6-MAM 6.4 
7. Heroin 82.9 7. 6-MAM 2.6 7. Heroin 49.4 
8. Fentanyl 82.0 8. Heroin 58.1 8. Fentanyl 71.0 






Table 5-4.  Pyromarkers of the pyrolysis of the 1:3 heroin to fentanyl mix. 
200 ˚C % Area 250 ˚C % Area 300 ˚C % Area 
1. Pyridine 12.5 1. Pyridine 22.2 1. Pyridine 45.4 
2. Styrene 11.5 2. Styrene 16.3 2. Styrene 24.3 
3. Benzaldehyde 5.1 3. Benzaldehyde 9.4 3. Benzaldehyde 20.2 
4. Phenylacetaldehyde 2.2 4. Phenylacetaldehyde 2.7 4. Phenylacetaldehyde 3.4 
5. Propionanilide 67.3 5. Acetylbenzoyl 0.8 5. Acetylbenzoyl 1.2 
6. 6-MAM 4.2 6. Propionanilide 73.7 6. Propionanilide 67.7 
7. Heroin 18.0 7. 6-MAM 2.2 7. 6-MAM 1.5 
8. Fentanyl 100 8. Heroin 20.4 8. Heroin 16.0 
  
  








350 ˚C % Area 400 ˚C % Area 450 ˚C % Area 
1. Pyridine 38.3 1. Pyridine 43.4 1. Pyridine 54.0 
2. Styrene 28.9 2. Styrene 31.3 2. Styrene 35.9 
3. Benzaldehyde 15.0 3. Benzaldehyde 17.5 3. Benzaldehyde 20.0 
4. Phenylacetaldehyde 4.5 4. Phenylacetaldehyde 4.5 4. Phenylacetaldehyde 6.1 
5. Acetylbenzoyl 1.4 5. Acetylbenzoyl 1.4 5. Propionanilide 70.7 
6. Propionanilide 96.9 6. Propionanilide 96.9 6. 6-MAM 5.1 
7. 6-MAM 1.0 7. Norfentanyl 0.5 7. Heroin 20.6 
8. Heroin 16.4 8. 6-MAM 0.7 8. Fentanyl 63.7 
9. Fentanyl 82.3 9. Heroin 15.6 
  
  






Overall, pyridine, styrene, benzaldehyde, phenylacetaldehyde, propionanilide, 6-
MAM, heroin, and fentanyl were common in all heroin to fentanyl mixes at all pyrolytic 
temperatures.  This is reasonable since only 6-MAM and heroin were observed for the 
pyrolysis of heroin HCl standard alone, despite pyromarkers reported in literature for the salt 
form of heroin.  Acetylbenzoyl was more prevalent in these mixes under different pyrolytic 
temperatures rather than what was observed of solely the drug fentanyl, where it was not seen 
in all three replicates.   
Future research should include the pyrolysis of these mixes using heroin base instead 
of the heroin HCl used.  These methods and procedure could be used for such an analysis in 
which there is potential to observe the other pyromarkers of heroin and if it does interact with 
the form pyromarkers of fentanyl.  Also, work could include the heroin and fentanyl mixes of 
both components in salt form and then converting the mixes in base form to pyrolyze.  It 
would be interesting to observe changes that this process could have an effect of the 


















Data obtained using the smoking box and thermocouple temperature probes clearly 
indicated that manufactured tobacco cigarette temperature studies were not applicable here.  
This simple study showed that the maximum temperature obtain while smoking FTPs under 
the “chasing the dragon” technique was approximately 450 °C in comparison to 750 °C.  
Nonetheless, similar pyromarkers were observed at both the lower and higher temperature of 
pyrolysis analysis.  The literature suggests that fentanyl is stable up to 350 °C, however, it is 
clear here that fentanyl thermally degraded as low as 200 ºC.   
In all cases, the following pyromarkers were consistently observed under all conditions 
were fentanyl standard and FTPs: pyridine, styrene, benzaldehyde, phenylacetaldehyde, 
propionanilide, and fentanyl.  Propionanilide was a major pyromarker that is prevalent under 
all conditions for both standards and FTPs, with the exception of the higher pyrolysis 
temperatures of FTPs where the plasticizer, 2-EH, had the highest peak area.  Although this 
plasticizer can be commonly found in the environment, it has the potential to be an additional 
marker for investigative purposes to link those who have smoked FTPs as mean of ingestion.   
For the heroin to fentanyl mixes, pyridine, styrene, benzaldehyde, phenylacetaldehyde, 
propionanilide, 6-MAM, heroin, and fentanyl were common in all pyrolytic temperatures and 
ratios.  These show similar pyromarkers, with the addition of 6-MAM and heroin, to the 
standalone fentanyl analysis.  Although not all literature pyromarkers were observed for 
heroin under this method, the stability and the combination of the pyromarkers that was seen 
here that can still be used for investigative purposes.   
Propionanilide was generally observed to have the highest peak area for throughout this 
project.  This pyromarker alone and/or the combination of the other pyromarkers have a 
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potential to be a marker in human biological samples to be indicative of the individual of 
having inhaled volatilized fentanyl.  
Little is known regarding human toxicity of these observed pyromarkers.  Pyridine, 
styrene, benzaldehyde, and phenylacetaldehyde are everywhere in the environment and the 
derivatives of propionanilide is a widely used hormone herbicide.120  Typically, these at high 
concentrations pose as skin and eye irritants.  The human oral lethal dose of pyridine is 0.5-
5.0 g/kg.121  The LD50 in rats for oral administration of benzaldehyde, phenylacetaldehyde, 
and propionanilide range between 1100-1500 mg/kg.122-124  The pyromarker with the lowest 
peak area for the pyrolysis of fentanyl standard was aniline, which has the lowest LD50 for 
rats of 250 mg/kg.125  It is not clear whether these pyromarkers would be considered more 
toxic than the drug itself, since little is known in regards to the human toxicity.  In either 
case, it is not known whether these pyromarkers would metabolize in the human body to 
other compounds.     
The work done here could be used to analyze other smoke drugs of abuse such as the 
newer designer drugs like bath salts, cannabinomimtics, Ritalin, etc.  Temperature 
assessment using the smoking box and the temperature probe could provide precise 
temperature of the drug and choice of method to smoke them.  Those parameters obtained 
can then be applied to the Py-GC/MS to mimic those smoking conditions and determine the 


























Appendix A: Thermocouple Data. 
 
  Smoke Observed Temp. Max. Temp. Rate Increase 
Trial T1 (°C) T2 (°C) T1 (°C) T2 (°C) T1 (°C/s) T2 (°C/s) 
1 69.7 128.5 248.6 286.5 13.2 15.4 
2* 166.7 247.2 166.7 372.5 15.9 24.9 
3 81.0 124.6 214.1 218.8 9.0 8.9 
4* 74.8 53.9 146.6 108.3 4.5 4.0 
5 315.1 308.6 345.7 357.9 20.2 21.0 
6 39.2 38.1 441.6 267.4 28.0 17.6 
7 35.3 36.2 289.4 376.1 16.7 23.6 
8 49.4 34.8 379.5 289.0 23.8 17.8 
9 33.8 63.0 268.1 256.9 14.5 13.8 
10 86.0 157.3 244.9 288.2 10.6 14.6 
11 45.6 65.0 320.6 387.0 17.6 22.8 
12 76.6 208.1 311.9 397.7 14.5 23.4 
13 69.2 66.9 222.8 224.2 8.3 8.8 
14 35.0 32.4 246.7 282.1 12.5 16.3 
15 22.4 22.3 254.4 225.2 12.9 11.9 
16 201.4 177.0 283.8 293.7 17.4 22.7 
Average 87.6 110.2 274.1 289.5 15.0 16.7 





Appendix B: Extended data of the pyromarkers of the pyrolysis of fentanyl standard and FTPs. 
 
Fentanyl Standards 
200 ˚C   Trial #1 Trial #2 Trial #3 Average 
Compound RT (min) Area % Area Area % Area Area % Area % Area 
Propionanilide 9.377 362246 100 821486 100 1821474 100 100 
Fentanyl 19.285 42245 11.7 69950 8.5 81259 4.5 8.2 
 
        
200 ˚C with 250 ˚C desorb   Trial #1 Trial #2 Trial #3 Average 
Compound RT (min) Area % Area Area % Area Area % Area % Area 
Pyridine 3.080 5939578 27.6 5449021 23.2 4291684 21.1 24.0 
Styrene 4.074 4500970 20.9 4352362 18.6 4145217 20.4 20.0 
Benzaldehyde 4.694 2847604 13.2 2743127 11.7 2394119 11.8 12.2 
Aniline 4.792 1035521 4.8 774770 3.3 697714 3.4 3.8 
Phenylacetaldehyde 5.437 605213 2.8 739240 3.2 538169 2.6 2.9 
1-Phenyl-1,2-propanedione  5.740 105415 0.5 183023 0.8       
Benzoic acid, methyl ester 5.932         92229 0.5   
Propionanilide 9.324 21512135 100 23447387 100 20351090 100 100 
N-(2-phenylethyl)-formamide 9.617     153470 0.7       
Azobenzene 10.934 106871 0.5           
Fentanyl 19.264 37389 0.2 1460802 6.2 581155 2.9 3.1 
 
        
250 ˚C    Trial #1 Trial #2 Trial #3 Average 
Compound RT (min) Area % Area Area % Area Area % Area % Area 
Pyridine 3.261 3572919 21.9 2737378 20.7 2429237 19.8 20.8 
Styrene 4.233 3794564 23.3 2837650 21.5 2544587 20.8 21.8 
Benzaldehyde 4.837 1608732 9.9 1075989 8.1 832241 6.8 8.3 
Aniline 4.931 256179 1.6 146084 1.1 24462 0.2 1.0 
Phenylacetaldehyde 5.567 543428 3.3 398155 3.0 426109 3.5 3.3 




1-Phenyl-1,2-propanedione  5.867 92413 0.6     51187 0.4   
Isothiocyanato-cyclohexane 7.625 195835 1.2           
Propionanilide 9.431 16315338 100 13211941 100 12249779 100 100 
N-(2-phenylethyl)-formamide 9.731     49774 0.4       
Fentanyl 19.287 3618244 22.2 735800 5.6 1170893 9.6 12.4 
 
        
300 ˚C    Trial #1 Trial #2 Trial #3 Average 
Compound RT (min) Area % Area Area % Area Area % Area % Area 
Pyridine 3.142 4239862 34.6 3079778 78.4 2503003 56.6 56.5 
Styrene 4.117 3307059 27.0 2540695 64.7 2216487 50.1 47.2 
Benzaldehyde 4.727 1980298 16.2 1401793 35.7 1226698 27.7 26.5 
Aniline 4.827 271332 2.2 135448 3.4 138588 3.1 2.9 
Phenylacetaldehyde 5.465 557313 4.5 466656 11.9 450030 10.2 8.9 
Phenylglyoxal 5.764     186939 4.8       
1-Phenyl-1,2-propanedione  5.788 141150 1.2     145839 3.3   
Propionanilide 9.334 12259111 100 3928913 100 4425958 100 100 
N-(2-phenylethyl)-formamide 9.637 43471 0.4 46780 1.2       
Fentanyl 19.296 5747589 46.9 1927851 49.1 4150003 93.8 63.2 
 
        
350 ˚C    Trial #1 Trial #2 Trial #3 Average 
Compound RT (min) Area % Area Area % Area Area % Area % Area 
Pyridine 3.116 4845712 37.7 3668289 87.2 1809296 50.7 58.5 
Styrene 4.103 3498986 27.3 3238319 77.0 1318662 36.9 47.1 
Benzaldehyde 4.718 2299901 17.9 1452773 34.5 751686 21.1 24.5 
Aniline 4.812 375804 2.9 128549 3.1 53675 1.5 2.5 
Phenylacetaldehyde 5.457 583222 4.5 474141 11.3 273693 7.7 7.8 
1-Phenyl-1,2-propanedione  5.783 147865 1.2           
Propionanilide 9.324 12838082 100 4206713 100 3569270 100 100 





        
400 ˚C    Trial #1 Trial #2 Trial #3 Average 
Compound RT (min) Area % Area Area % Area Area % Area % Area 
Pyridine 3.117 6972996 31.4 5955515 45.7 4938345 61.3 46.2 
3-Methyl-pyridine 3.846     141228 1.1 126585 1.6   
Styrene 4.103 5843127 26.4 4739549 36.4 4268022 53.0 38.6 
Benzaldehyde 4.717 3983829 18.0 2362817 18.1 1965474 24.4 20.2 
Aniline 4.814 247944 1.1 190130 1.5 165959 2.1 1.5 
Benzonitrile 4.904         89583 1.1   
Benzyl Alcohol 5.329     78912 0.6 61182 0.8   
Phenylacetaldehyde 5.457 1005396 4.5 738430 5.7 688247 8.5 6.3 
Phenylglyoxal 5.759     219988 1.7 187794 2.3   
1-Phenyl-1,2-propanedione  5.759 218822 1.0           
Phthalic anhydride 8.142     47812 0.4       
Propionanilide 9.324 22174011 100 13022329 100 8051227 100 100 
N-(2-phenylethyl)-formamide 9.631     77094 0.6 81733 1.0   
Fentanyl 19.290 18562786 83.7 7209262 55.4 4626583 57.5 65.5 
 
        
450 ˚C    Trial #1 Trial #2 Trial #3 Average 
Compound RT (min) Area % Area Area % Area Area % Area % Area 
Pyridine 3.121 8614939 50.9 8597279 43.3 5059816 32.4 42.2 
3-Methyl-pyridine 3.846 168320 1.0 134164 0.7 258169 1.7 1.1 
Styrene 4.107 6376814 37.6 6542358 33.0 4121522 26.4 32.3 
Benzaldehyde 4.719 4728881 27.9 4559441 23.0 1939635 12.4 21.1 
Aniline 4.823 1105614 6.5 717335 3.6 198378 1.3 3.8 
Benzonitrile 4.899     186140 0.9       
Benzyl Alcohol 5.330         82501 0.5   
Phenylacetaldehyde 5.459 756888 4.5 906590 4.6 616100 3.9 4.3 




Phthalic anhydride 8.163     64465 0.3       
Propionanilide 9.330 16939476 100 19839327 100 15629638 100 100 
N-(2-phenylethyl)-formamide 9.633     87799 0.4 100800 0.6   
Azobenzene 10.989 107059 0.6 70750 0.4      
Fentanyl 19.292 180978 1.1 1703020 8.6 10032023 64.2 24.6 
 
FTPs 
200 ˚C   Trial #1 Trial #2 Trial #3 Average 
Compound RT (min) Area % Area Area % Area Area % Area % Area 
Pyridine 3.099 1174722 19.8 1584118 20.5 1120842 25.4 21.9 
Styrene 4.089 1857401 31.3 1832391 23.7 999575 22.7 25.9 
Benzaldehyde 4.697 757351 12.8 889564 11.5 485626 11.0 11.8 
Phenylacetaldehyde 5.449 499583 8.4 819594 10.6 370116 8.4 9.1 
Propionanilide 9.333 5929884 100 7716474 100 4408695 100 100 
Fentanyl 19.262 127672 2.2 125871 1.6 101860 2.3 2.0 
 
        
200 ˚C with 250 ˚C desorb Trial #3 Trial #1 Trial #2 Trial #3 Average 
Compound RT (min) Area % Area Area % Area Area % Area % Area 
Pyridine 3.033 453716 13.4 434242 14.5 669399 15.8 14.6 
Styrene 4.049 915139 27.0 706582 23.6 782192 18.5 23.0 
Benzaldehyde 4.672 248490 7.3 214076 7.2 400799 9.5 8.0 
Phenylacetaldehyde 5.420 257017 7.6 197614 6.6 318023 7.5 7.2 
Propionanilide 9.307 3387918 100 2993393 100 4234396 100 100 
Fentanyl 19.268 524291 15.5 466113 15.6 746520 17.6 16.2 
 
        
250 ˚C    Trial #1 Trial #2 Trial #3 Average 
Compound RT (min) Area % Area Area % Area Area % Area % Area 
Methyl formate 2.363         194764 1.6   




3-Methylene-heptane 3.216         424316 3.4   
Styrene 4.046 6249682 37.2 3880539 29.4 4024155 32.7 33.1 
2-Ethyl-hexanal 4.485 177225 1.1     191364 1.6   
Benzaldehyde 4.667 2570474 15.3 2514348 19.1 2202299 17.9 17.4 
Aniline 4.769 267022 1.6 381918 2.9 242562 2.0 2.2 
3-Pyridinecarboxaldehyde 4.998 168249 1.0 147578 1.1 128754 1.0 1.1 
2-EH 5.147         510698 4.2   
Benzyl Alcohol 5.284 137351 0.8 87079 0.7 87003 0.7 0.7 
Phenylacetaldehyde 5.417 1469933 8.7 747348 5.7 916529 7.4 7.3 
1-Phenyl-1,2-propanedione 5.722 193995 1.2 245588 1.9 177907 1.4 1.5 
Benzenecarboxylic acid 6.381 184751 1.1 132061 1.0 180713 1.5 1.2 
Propionanilide 9.317 16808919 100 13187542 100 12303657 100 100 
N-(2-phenylethyl)-formamide  9.612 284173 1.7 294823 2.2 251358 2.0 2.0 
Fentanyl 19.263 73189 0.4 197784 1.5 314725 2.6 1.5 
 
        
300 ˚C    Trial #1 Trial #2 Trial #3 Average 
Compound RT (min) Area % Area Area % Area Area % Area % Area 
Pyridine 3.021 4394098 35.4 3815696 26.4 4337389 29.7 30.5 
3-Methylene-heptane 3.210 6534789 52.6 4276059 29.6 5975715 40.9 41.1 
3-Heptanone 3.870 1645940 13.3 526918 3.7 953806 6.5 7.8 
Styrene 4.036 4496873 36.2 3579109 24.8 4941010 33.8 31.6 
2-Ethyl-2-hexenal 4.209 380592 3.1 201238 1.4 283967 1.9 2.1 
2-Ethyl-hexanal 4.477 3084532 24.8 1305480 9.0 1677692 11.5 15.1 
Benzaldehyde 4.662 4371825 35.2 3054965 21.2 3391789 23.2 26.5 
Aniline 4.767 419414 3.4           
2-EH 5.142 8470103 68.2 6772988 46.9 8463971 57.9 57.7 
Benzyl Alcohol 5.286     290241 2.0 357358 2.4   
Phenylacetaldehyde 5.413 1154824 9.3 1489212 10.3 1565208 10.7 10.1 




2-Ethylhexyl ester acetic acid 6.278 176039 1.4 141742 1.0 182871 1.3 1.2 
Benzenecarboxylic acid 6.376 459858 3.7 407890 2.8 520743 3.6 3.4 
2-Ethylhexyl ester 2-propenoic acid  7.084 903269 7.3 754311 5.2 1044978 7.2 6.6 
2-Ethylhexyl methacrylate 7.838 112829 0.9           
Phthalic anhydride 8.115 120630 1.0 106943 0.7       
Propionanilide 9.314 12412608 100 14435342 100 14614471 100 100 
Acrylanilide 9.363 115729 0.9           
N-(2-phenylethyl)-formamide 9.611 288808 2.3 318006 2.2 377024 2.6 2.4 
2-EEFA 10.290 382202 3.1 241536 1.7 315548 2.2 2.3 
Fentanyl 19.267 20166 0.2 322358 2.2 423443 2.9 1.8 
 
        
350 ˚C    Trial #1 Trial #2 Trial #3 Average 
Compound RT (min) Area % Area Area % Area Area % Area % Area 
Pyridine 3.018 5007167 34.7 4617613 31.8 4375933 29.6 32.0 
3-Methylene-heptane 3.212 5938456 41.2 4330641 29.8 5509295 37.2 36.1 
3-Heptanone 3.867 680975 4.7 687879 4.7 872715 5.9 5.1 
Styrene 4.035 5484007 38.0 5163947 35.5 4315403 29.2 34.2 
2-Ethyl-2-hexenal 4.215 296156 2.1           
2-Ethyl-hexanal 4.471 1340437 9.3 1276284 8.8 2110434 14.3 10.8 
Benzaldehyde 4.662 4096522 28.4 4034306 27.8 3944706 26.7 27.6 
Aniline 4.763 398659 2.8 257240 1.8       
2-EH 5.141 9049021 62.8 6088817 41.9 9266297 62.6 55.8 
Benzyl Alcohol 5.283 333796 2.3 278392 1.9 187403 1.3 1.8 
Phenylacetaldehyde 5.412 1389825 9.6 1347572 9.3 896213 6.1 8.3 
1-Phenyl-1,2-propanedione  5.716 290698 2.0 196429 1.4       
2-Ethylhexyl ester acetic acid 6.278 195482 1.4 141558 1.0 137994 0.9 1.1 
Benzenecarboxylic acid 6.377 500283 3.5 331292 2.3 409448 2.8 2.8 
2-Ethylhexyl ester 2-propenoic acid 7.084 918112 6.4 500482 3.4 692837 4.7 4.8 




Propionanilide 9.316 14415944 100 14534791 100 14797242 100 100 
Acrylanilide 9.363     133545 0.9 118115 0.8   
N-(2-phenylethyl)-formamide  9.612 329710 2.3     442899 3.0   
2-EEFA 10.290 361085 2.5 193354 1.3 378222 2.6 2.1 
Fentanyl 19.267 219598 1.5 213646 1.5 289585 2.0 1.7 
 
        
400 ˚C    Trial #1 Trial #2 Trial #3 Average 
Compound RT (min) Area % Area Area % Area Area % Area % Area 
Pyridine 3.019 4075441 18.7 5375025 24.0 6757820 26.9 23.2 
3-Methylene-heptane 3.208 10180024 46.7 11440491 51.0 13149918 52.4 50.0 
3-Heptanone 3.867 1268850 5.8 1278998 5.7 1319572 5.3 5.6 
Styrene 4.032 3403062 15.6 4004466 17.8 5023552 20.0 17.8 
2-Ethyl-2-hexenal 4.207 742942 3.4 803378 3.6 669983 2.7 3.2 
2-Ethyl-hexanal 4.473 2995224 13.7 3284885 14.6 3084095 12.3 13.6 
Benzaldehyde 4.659 4107472 18.8 4787727 21.3 5808772 23.2 21.1 
2-EH 5.141 21795820 100 22435959 100 25087109 100 100 
Phenylacetaldehyde 5.410 939843 4.3 988776 4.4 1558080 6.2 5.0 
2-Ethylhexyl ester acetic acid 6.276 345049 1.6 378476 1.7 564615 2.3 1.8 
Benzenecarboxylic acid 6.382 588258 2.7 548783 2.4 707275 2.8 2.7 
2-Ethylhexyl ester 2-propenoic acid  7.083 2804275 12.9 2713098 12.1 3613154 14.4 13.1 
2-Ethylhexyl methacrylate 7.836 360879 1.7 365715 1.6 406327 1.6 1.6 
2-EECA 8.609 408126 1.9 405280 1.8 466286 1.9 1.8 
Butyl 2-ethylhexyl ester sulfurous acid 8.791         263892 1.1   
Propionanilide 9.319 13467368 61.8 14903654 66.4 19821574 79.0 69.1 
2-Ethylhexyl ester pentanoic acid  9.637 934487 4.3 934811 4.2 763266 3.0 3.8 
2-EEFA 10.288 813202 3.7 928862 4.1 899133 3.6 3.8 
Fentanyl 19.264 1499527 6.9 78130 0.3 198013 0.8 2.7 
 
        




Compound RT (min) Area % Area Area % Area Area % Area % Area 
Pyridine 3.017 9734424 21.2 7903034 21.9 6348045 27.3 23.5 
3-Methylene-heptane  3.206 30031724 65.5 23002960 63.7 15959897 68.6 65.9 
3-Heptanone 3.863 2965207 6.5 2171713 6.0 2595286 11.2 7.9 
Styrene 4.029 5215870 11.4 4198655 11.6 4062135 17.5 13.5 
2-Ethyl-hexanal 4.470 5077234 11.1 3883741 10.7 3723561 16.0 12.6 
Benzaldehyde 4.654 10988711 24.0 9112778 25.2 6807454 29.2 26.1 
2-EH 5.139 45832553 100 36134710 100 23274294 100 100 
Phenylacetaldehyde 5.407 1873290 4.1 1352711 3.7 1110295 4.8 4.2 
2-Ethylhexyl ester acetic acid  6.274 2075541 4.5 1514618 4.2 957883 4.1 4.3 
Benzenecarboxylic acid 6.386 1696268 3.7 869219 2.4 922505 4.0 3.4 
6-Methylheptyl ester 2-propenoic acid 7.079 12678473 27.7 10943290 30.3 6016383 25.8 27.9 
2-Ethylhexyl methacrylate 7.832 1665919 3.6 927896 2.6 718823 3.1 3.1 
n-Butyric acid 2-ethylhexyl ester 7.970 674654 1.5 423399 1.2 295891 1.3 1.3 
2-EECA 8.605 1286234 2.8 1022424 2.8 547821 2.4 2.7 
Propionanilide 9.317 26278124 57.3 21534669 59.6 16798918 72.2 63.0 
2-Ethylhexyl ester pentanoic acid 9.633 2462353 5.4 1821194 5.0 1201459 5.2 5.2 
2-EEFA 10.284 1042763 2.3 459647 1.3 481726 2.1 1.9 







Appendix C: Extended data and GC Chromatograms of the pyromarkers of the pyrolysis of heroin and 
fentanyl mixes. 
 
3:1 Heroin to Fentanyl Mix 
200 ˚C   Trial #1 Trial #2 Trial #3 Average 
Compound RT (min) Area % Area Area % Area Area % Area % Area 
Pyridine 3.082 427125 1.7 1025486 5.6 1340271 6.7 4.7 
Styrene 4.073 353368 1.4 857860 4.7 936433 4.7 3.6 
Benzaldehyde 4.692 174712 0.7 424453 2.3 473994 2.4 1.8 
Aniline 4.784     58580 0.3 67187 0.3   
Phenylacetaldehyde 5.433 91625 0.4 159302 0.9 218861 1.1 0.8 
Acetylbenzoyl 5.736     63068 0.3 75212 0.4   
Propionanilide 9.306 5094048 20.3 6047432 33.1 6798119 34.1 29.1 
Norfentanyl 13.511 46558 0.2 25679 0.1 50073 0.3 0.2 
6-MAM 17.509 1555767 6.2 1057359 5.8 1307222 6.6 6.2 
Heroin 18.391 25139123 100 18289879 100 19926264 100 100 
Fentanyl 19.275 5020428 20.0 4034237 22.1 4599114 23.1 21.7 
                  
250 ˚C   Trial #1 Trial #2 Trial #3 Average 
Compound RT (min) Area % Area Area % Area Area % Area % Area 
Pyridine 3.087 852063 3.6 1025486 5.6 1726495 15.2 8.1 
Styrene 4.077 699069 3.0 857860 4.7 1026517 9.0 5.6 
Benzaldehyde 4.691 285818 1.2 424453 2.3 881822 7.8 3.8 
Aniline 4.792     58580 0.3 122678 1.1   
Phenylacetaldehyde 5.432 124750 0.5 159302 0.9 165779 1.5 1.0 
Acetylbenzoyl 5.734 52547 0.2 63068 0.3 68516 0.6 0.4 
Propionanilide 9.300 4844623 20.5 6047432 33.1 3816356 33.6 29.1 
6-MAM 17.505 3538088 15.0 1057359 5.8 578118 5.1 8.6 




Fentanyl 19.271 7353089 31.1 4034237 22.1 1381941 12.2 21.8 
                  
300 ˚C   Trial #1 Trial #2 Trial #3 Average 
Compound RT (min) Area % Area Area % Area Area % Area % Area 
Pyridine 3.088 1011904 5.8 2649647 15.5 2096698 21.0 14.1 
Styrene 4.075 836633 4.8 1939014 11.3 1133958 11.4 9.2 
Benzaldehyde 4.691 376413 2.2 978972 5.7 918998 9.2 5.7 
Aniline 4.788     106457 0.6 92631 0.9   
Benzonitirile 4.875     106144 0.6       
Phenylacetaldehyde 5.429 133316 0.8 232943 1.4 193407 1.9 1.4 
Acetylbenzoyl  5.737     99430 0.6       
Propionanilide 9.302 4859169 27.9 5044613 29.5 3702009 37.1 31.5 
6-MAM 17.509 2382366 13.7 1892883 11.1 374971 3.8 9.5 
Heroin 18.390 17391367 100 17113311 100 9972884 100 100 
Fentanyl 19.270 3994111 23.0 3349170 19.6 1449919 14.5 19.0 
                  
350 ˚C   Trial #1 Trial #2 Trial #3 Average 
Compound RT (min) Area % Area Area % Area Area % Area % Area 
Pyridine 3.089 974999 10.6 2403074 22.8 2499290 21.5 18.3 
Styrene 4.076 651515 7.1 1358441 12.9 1342649 11.5 10.5 
Benzaldehyde 4.692 557485 6.1 1014230 9.6 1068560 9.2 8.3 
Aniline 4.79     122235 1.2 105475 0.9   
Benzonitrile 4.872     98579 0.9       
Phenylacetaldehyde 5.430 116738 1.3 219050 2.1 251754 2.2 1.8 
Acetylbenzoyl  5.733     87890 0.8 93861 0.8   
Propionanilide 9.299 3512393 38.1 3931018 37.4 4314069 37.0 37.5 
6-MAM 17.501 520099 5.6 277603 2.6 431403 3.7 4.0 
Heroin 18.377 9213391 100 10518754 100 11649292 100 100 




                  
400 ˚C   Trial #1 Trial #2 Trial #3 Average 
Compound RT (min) Area % Area Area % Area Area % Area % Area 
Pyridine 3.088 1508048 12.9 2619511 20.3 2246331 22.8 18.7 
Styrene 4.077 1154659 9.9 1639437 12.7 1382670 14.1 12.2 
Benzaldehyde 4.691 689837 5.9 1072694 8.3 927865 9.4 7.9 
Aniline 4.784     132486 1.0       
Benzonitrile 4.871         94087 1.0   
Phenylacetaldehyde 5.43 178513 1.5 213573 1.7 188028 1.9 1.7 
Acetylbenzoyl  5.732   0.0 75356 0.6 72266 0.7   
Phthalic anhydride 8.166 50878 0.4           
Propionanilide 9.299 5124945 43.8 4033329 31.3 3062012 31.1 35.4 
6-MAM 17.502 325164 2.8 428586 3.3 351808 3.6 3.2 
Heroin 18.379 11705004 100 12891518 100 9831045 100 100 
Fentanyl 19.267 1328710 11.4 1532001 11.9 1035027 10.5 11.3 
                  
450 ˚C   Trial #1 Trial #2 Trial #3 Average 
Compound RT (min) Area % Area Area % Area Area % Area % Area 
Pyridine 3.143 1524262 4.6 3530622 51.4 2348809 10.3 22.1 
Styrene 4.12 1012630 3.1 2256962 32.9 1617539 7.1 14.4 
Benzaldehyde 4.729 649691 2.0 1203888 17.5 898336 4.0 7.8 
Phenylacetaldehyde 5.463 208919 0.6 343847 5.0 281550 1.2 2.3 
Acetylbenzoyl  5.766     148537 2.2       
Propionanilide 9.325 7299502 22.1 2647695 38.6 9959385 43.9 34.9 
Norfentanyl 13.521         107615 0.5   
6-MAM 17.528 2247466 6.8 842975 12.3 7267983 32.0 17.0 
Heroin 18.403 32965334 100 6862895 100 22701106 100 100 





1:1 Heroin to Fentanyl Mix 
200 ˚C   Trial #1 Trial #2 Trial #3 Average 
Compound RT (min) Area % Area Area % Area Area % Area % Area 
Pyridine 3.084 1106715 6.3 1963516 10.8 2623180 13.8 10.3 
Styrene 4.076 947187 5.4 1787957 9.8 2292694 12.1 9.1 
Benzaldehyde 4.690 309520 1.8 722239 4.0 1087617 5.7 3.8 
Aniline 4.784   0.0 77173 0.4 241858 1.3   
Phenylacetaldehyde 5.431 204072 1.2 397955 2.2 422599 2.2 1.9 
Acetylbenzoyl 5.733 57874 0.3 97432 0.5 104884 0.6 0.5 
Propionanilide 9.305 9509159 53.8 12917882 71.0 12826091 67.6 64.1 
Norfentanyl 13.497 79533 0.5 183653 1.0 221110 1.2 0.9 
6-MAM 17.494 1130945 6.4 1113491 6.1 1875776 9.9 7.5 
Heroin 18.370 17673836 100 16565965 91.0 17067313 90.0 93.7 
Fentanyl 19.264 15925706 90.1 18203484 100 18966113 100 96.7 
                  
250 ˚C    Trial #1 Trial #2 Trial #3 Average 
Compound RT (min) Area % Area Area % Area Area % Area % Area 
Pyridine 3.091 1648630 8.4 3797643 26.2 4024882 23.8 19.4 
Styrene 4.078 1363144 6.9 2595296 17.9 2987687 17.7 14.2 
Benzaldehyde 4.692 415025 2.1 1505520 10.4 1491748 8.8 7.1 
Aniline 4.791     147632 1.0       
Phenylacetaldehyde 5.432 250671 1.3 488198 3.4 567651 3.4 2.7 
Acetylbenzoyl 5.730 74496 0.4 158243 1.1 174696 1.0 0.8 
Isothiocyanato-cyclohexane 7.564 132391 0.7   0.0       
Propionanilide 9.304 10569080 53.6 12014280 82.8 13196551 78.0 71.5 
Norfentanyl 13.495     124623 0.9 127016     
6-MAM 17.492 2452277 12.4 917676 6.3 921671 5.4 8.1 
Heroin 18.370 19727933 100 13197787 91.0 14810783 87.5 92.8 




                  
300 ˚C    Trial #1 Trial #2 Trial #3 Average 
Compound RT (min) Area % Area Area % Area Area % Area % Area 
Pyridine 3.094 2158365 23.8 4672080 36.5 4662451 40.4 33.6 
Styrene 4.081 1740787 19.2 2965312 23.2 2858251 24.8 22.4 
Benzaldehyde 4.692 845912 9.3 2022480 15.8 1985057 17.2 14.1 
Aniline 4.792         200051 1.7   
Benzonitrile 4.879     173656 1.4 155069 1.3   
Phenylacetaldehyde 5.432 293522 3.2 498044 3.9 533755 4.6 3.9 
Acetylbenzoyl 5.731         183969 1.6   
Phthalic anhydride 8.115     59599 0.5 76991 0.7   
Propionanilide 9.304 8985753 99.0 10484422 82.0 11123282 96.5 92.5 
Norfentanyl 13.499     98637 0.8 86796 0.8   
6-MAM 17.494 786149 8.7 1191441 9.3 840717 7.3 8.4 
Heroin 18.369 9076491 100 11872286 92.9 10729043 93.1 95.3 
Fentanyl 19.262 8866628 97.7 12783235 100 11529365 100 99.2 
                  
350 ˚C    Trial #1 Trial #2 Trial #3 Average 
Compound RT (min) Area % Area Area % Area Area % Area % Area 
Pyridine 3.095 2256598 30.3 5187093 38.9 4787853 31.3 33.5 
Styrene 4.079 1885619 25.3 3091721 23.2 3222107 21.1 23.2 
Benzaldehyde 4.692 892174 12.0 2294462 17.2 1962840 12.8 14.0 
Phenylacetaldehyde 5.431 257583 3.5 588078 4.4 546698 3.6 3.8 
Acetylbenzoyl 5.734 81199 1.1     186201 1.2   
Phthalic anhydride 8.171 37321 0.5           
Propionanilide 9.304 7444606 100 13339386 100 12042474 78.8 92.9 
Norfentanyl 13.498     126643 0.9 122799 0.8   
6-MAM 17.497 285379 3.8 986108 7.4 1956774 12.8 8.0 




Fentanyl 19.267 5053706 67.9 10429151 78.2 15290413 100 82.0 
                  
400 ˚C    Trial #1 Trial #2 Trial #3 Average 
Compound RT (min) Area % Area Area % Area Area % Area % Area 
Pyridine 3.091 2428066 31.0 5092072 51.2 5718865 43.8 42.0 
Styrene 4.079 1744946 22.3 2600402 26.2 3391013 26.0 24.8 
Benzaldehyde 4.691 1153720 14.7 2372587 23.9 2482115 19.0 19.2 
Benzonitrile 4.878     214899 2.2       
Phenylacetaldehyde 5.430 296573 3.8 504254 5.1 585103 4.5 4.4 
Acetylbenzoyl 5.734 90139 1.2     228259 1.7   
Phthalic anhydride 8.114 43148 0.6 82634 0.8 89964 0.7 0.7 
Propionanilide 9.305 7826342 100 9939990 100 13053301 100 100 
Norfentanyl 13.496         69996 0.5   
6-MAM 17.500 171985 2.2 203137 2.0 470712 3.6 2.6 
Heroin 18.366 5949818 76.0 3968302 39.9 7603335 58.2 58.1 
Fentanyl 19.261 3319345 42.4 2591005 26.1 6836278 52.4 40.3 
                  
450 ˚C    Trial #1 Trial #2 Trial #3 Average 
Compound RT (min) Area % Area Area % Area Area % Area % Area 
Pyridine 3.138 3326437 39.8 915343 37.0 1665125 67.3 48.0 
Styrene 4.115 2456511 29.4 609203 24.6 1310586 53.0 35.7 
Benzaldehyde 4.725 1732791 20.7 286982 11.6 835978 33.8 22.0 
Aniline 4.829 175212 2.1     75593 3.1   
Phenylacetaldehyde 5.462 297860 3.6 91692 3.7 230824 9.3 5.5 
Acetylbenzoyl 5.786 99536 1.2           
Propionanilide 9.323 8360483 100 801917 32.4 1851205 74.9 69.1 
6-MAM 17.523 51454 0.6 205569 8.3 253828 10.3 6.4 
Heroin 18.395 3414052 40.8 996359 40.3 1661372 67.2 49.4 




1:3 Heroin to Fentanyl Mix 
200 ˚C   Trial #1 Trial #2 Trial #3 Average 
Compound RT (min) Area % Area Area % Area Area % Area % Area 
Pyridine 3.083 1461784 8.6 3521836 11.9 4717374 16.8 12.5 
Styrene 4.075 1628668 9.6 3182182 10.8 3963862 14.1 11.5 
Benzaldehyde 4.692 519299 3.1 1491855 5.0 2020698 7.2 5.1 
Phenylacetaldehyde 5.430 291565 1.7 635000 2.1 802720 2.9 2.2 
Acetylbenzoyl 5.856 63443 0.4           
Propionanilide 9.316 11067919 65.5 18923590 64.0 20335617 72.4 67.3 
N-(2-phenylethyl)-formamide 9.606     57328 0.2 73871 0.3   
Norfentanyl 13.496     217260 0.7 215350 0.8   
6-MAM 17.480 389732 2.3 1394198 4.7 1605513 5.7 4.2 
Heroin 18.339 2686647 15.9 5845676 19.8 5113120 18.2 18.0 
Fentanyl 19.248 16902522 100 29558706 100 28069395 100 100 
 
                
250 ˚C   Trial #1 Trial #2 Trial #3 Average 
Compound RT (min) Area % Area Area % Area Area % Area % Area 
Pyridine 3.089 3218908 28.3 5212996 17.4 5848535 20.9 22.2 
Styrene 4.077 2409551 21.2 3648197 12.2 4341288 15.5 16.3 
Benzaldehyde 4.692 1380504 12.1 2189712 7.3 2424710 8.7 9.4 
Aniline 4.793 358250 3.2 328143 1.1       
Phenylacetaldehyde 5.432 323627 2.8 684887 2.3 793078 2.8 2.7 
Acetylbenzoyl 5.735 91005 0.8 197361 0.7 232550 0.8 0.8 
Propionanilide 9.313 11368092 100 16872011 56.4 18090895 64.7 73.7 
N-(2-phenylethyl)-formamide 9.605         67179 0.2   
Norfentanyl 13.493     155110 0.5 201272 0.7   
6-MAM 17.478 179332 1.6 606577 2.0 864436 3.1 2.2 
Heroin 18.345 1896847 16.7 6761275 22.6 6134716 21.9 20.4 





                
300 ˚C   Trial #1 Trial #2 Trial #3 Average 
Compound RT (min) Area % Area Area % Area Area % Area % Area 
Pyridine 3.093 3115480 9.9 8178317 100.0 6866035 26.4 45.4 
Phenylethyne 3.933     70667 0.9       
Styrene 4.080 2212389 7.0 4018461 49.1 4383899 16.8 24.3 
Benzaldehyde 4.693 1197178 3.8 3632648 44.4 3203154 12.3 20.2 
Benzonitrile 4.872     326031 4.0       
Benzoxazole 5.217     69912 0.9       
Phenylacetaldehyde 5.431 452046 1.4 462080 5.7 816311 3.1 3.4 
Acetylbenzoyl 5.733 140400 0.4 169009 2.1 249728 1.0 1.2 
Phthalic anhydride 8.115         77435 0.3   
Propionanilide 9.309 12820902 40.8 7938451 97.1 16943450 65.1 67.7 
Azobenzene 10.928     102838 1.3       
Norfentanyl 13.488         139117 0.5   
6-MAM 17.474 607716 1.9 28053 0.3 598445 2.3 1.5 
Heroin 18.341 6514358 20.7 351007 4.3 5950385 22.8 16.0 
Fentanyl 19.241 31397447 100 309065 3.8 26041394 100 67.9 
 
                
350 ˚C   Trial #1 Trial #2 Trial #3 Average 
Compound RT (min) Area % Area Area % Area Area % Area % Area 
Pyridine 3.091 3062943 32.4 7180368 41.5 7940002 40.9 38.3 
Styrene 4.076 2490113 26.4 5217575 30.2 5885985 30.3 28.9 
Benzaldehyde 4.689 1317977 13.9 2695383 15.6 3012354 15.5 15.0 
Aniline 4.789 137722 1.5 304021 1.8       
Benzonitrile 4.875         225151 1.2   
Phenylacetaldehyde 5.427 389348 4.1 838200 4.8 898867 4.6 4.5 
Acetylbenzoyl 5.729 99239 1.1 263501 1.5 305404 1.6 1.4 




Propionanilide 9.308 9448930 100 16789818 97.1 18195805 93.6 96.9 
N-(2-phenylethyl)-formamide 9.601         63208 0.3   
Norfentanyl 13.499         95481 0.5   
6-MAM 17.491 9730 0.1 252186 1.5 275057 1.4 1.0 
Heroin 18.358 693618 7.3 3584401 20.7 4092342 21.1 16.4 
Fentanyl 19.263 4436447 47.0 17283755 100 19432079 100 82.3 
 
                
400 ˚C   Trial #1 Trial #2 Trial #3 Average 
Compound RT (min) Area % Area Area % Area Area % Area % Area 
Pyridine 3.093 5500189 38.6 8671796 51.9 6984427 39.8 43.4 
Styrene 4.078 4839220 33.9 6011796 36.0 4182648 23.8 31.3 
Benzaldehyde 4.690 2473203 17.3 3274332 19.6 2733848 15.6 17.5 
Benzonitrile 4.879     215480 1.3       
Phenylacetaldehyde 5.428 597690 4.2 776247 4.6 794230 4.5 4.5 
Acetylbenzoyl 5.729 150940 1.1 267496 1.6 279152 1.6 1.4 
Phthalic anhydride 8.110     74009 0.4 73374 0.4   
Propionanilide 9.305 14266149 100 16701184 100 15899473 90.7 96.9 
Norfentanyl 13.496 85155 0.6 59458 0.4 78561 0.4 0.5 
6-MAM 17.489 9476 0.1 131203 0.8 208156 1.2 0.7 
Heroin 18.358 553879 3.9 2672195 16.0 4733121 27.0 15.6 
Fentanyl 19.260 3840375 26.9 6433219 38.5 17538159 100 55.1 
 
                
450 ˚C   Trial #1 Trial #2 Trial #3 Average 
Compound RT (min) Area % Area Area % Area Area % Area % Area 
Pyridine 3.083 5007970 38.3 10501543 23.8 2463071 100 54.0 
Styrene 4.084 4169439 31.9 7751148 17.6 1434261 58.2 35.9 
Benzaldehyde 4.702 2152395 16.5 3486491 7.9 876852 35.6 20.0 
Aniline 4.807         140136 5.7   




Acetylbenzoyl 5.777 136821 1.0           
Monoethyl ester phthalic acid 8.144     118386 0.3       
Propionanilide 9.322 13070145 100 9898687 22.5 2207919 89.6 70.7 
Norfentanyl 13.520     190647 0.4 22319 0.9   
6-MAM 17.518 30395 0.2 3973140 9.0 150384 6.1 5.1 
Heroin 18.387 673423 5.2 14981797 34.0 559021 22.7 20.6 








Pyrolysis of Heroin at 200 ˚C 
 
 Pyrolysis of Heroin at 450 ˚C 
 


















Pyrolysis of 3:1 Heroin to Fentanyl Mix at 250 ˚C 
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Pyrolysis of 3:1 Heroin to Fentanyl Mix at 400 ˚C 
 
Pyrolysis of 3:1 Heroin to Fentanyl Mix at 450 ˚C 
 








Pyrolysis of 1:1 Heroin to Fentanyl Mix at 250 ˚C 
 
Pyrolysis of 1:1 Heroin to Fentanyl Mix at 300 ˚C 
 








Pyrolysis of 1:1 Heroin to Fentanyl Mix at 400 ˚C 
 
Pyrolysis of 1:1 Heroin to Fentanyl Mix at 450 ˚C 
 








Pyrolysis of 1:3 Heroin to Fentanyl Mix at 250 ˚C 
 
Pyrolysis of 1:3 Heroin to Fentanyl Mix at 300 ˚C 
 








Pyrolysis of 1:3 Heroin to Fentanyl Mix at 400 ˚C 
 
















1. Drugs of Abuse. Joseph, D. E., Ed. Drug Enforcement Administration: U.S. 
Department of Justice: 2005. 
2. Commonly Abused Drugs. National Institute of Drug Abuse: 2010. 
3. Fenton, J. J., Toxicology: A Case-Oriented Approach. CRC Press: Boca Raton, FL, 
2001. 
4. Shafizadeh, F., The Chemistry of Pyrolysis and Combustion. Adv. Chem. Ser. 1984,  
(207), 491-529. 
5. Applied Pyrolysis Handbook. 2nd ed.; Taylor & Francis Group: Boca Raton, FL, 
2007; p 1-288. 
6. Meng, Y.; Lichtman, A. H.; Bridgen, T.; Martin, B. R., Inhalation Studies with Drugs 
of Abuse. National Institute on Drug Abuse Research Monograph 1997, 173, 201-
224. 
7. Klous, M. G.; Van den Brink, W.; Van Ree, J. M.; Beijnen, J. H., Development of 
Pharmaceutical Heroin Preparations for Medical Co-Prescription to Opioid 
Dependent Patients. Drug Alcohol Depend. 2005, 80 (3), 283-295. 
8. Wesson, D. R., Current Patterns of Drug Abuse That Involve Smoking. National 
Institute on Drug Abuse Research Monograph 1990, 99, 5-11. 
9. Inchiosa, M. A., Toxicokinetics: Deposition, Absorption, Distribution, and Excretion. 
In Inhalation Toxicology, 2nd ed.; Salem, H.; Katz, S. A., Eds. CRC Press: Boca 
Raton, FL, 2006. 
10. Pharmacokinetics and Pharmacodynamics of Abused Drugs. CRC Press: Boca Raton, 
FL, 2008. 
11. Menzel, D. B.; McClellan, R. O., Toxic Responses and the Respiratory System. In 
Casarett and Doull's Toxicology, 2nd ed.; Doull, J.; Klaassen, C. D.; Amdur, M. O., 
Eds. Macmillan Publishing Co.: New York, 1980; pp 246-274. 
12. Guyton, A. C., Textbook of Medical Physiology. 11th ed.; Elsevier Saunders: 
Philadelphia, 2006. 
13. Weibel, E. R., Morphometry of the Human Lung. Springer: Berlin, 1963. 
14. von Hayek, H., The Human Lung. Hafner Pub. Co.: New York, NY, 1960. 
15. Castell, J. V.; Donato, M. T.; Gomez-Lechon, M. J., Metabolism and Bioactivation of 
Toxicants in the Lung. The in Vitro Cellular Approach. Exp. Toxicol. Pathol. 2005, 
57, 189-204. 
16. Tan, T. P.; Algra, P. R.; Valk, J.; Wolters, E. C., Toxic Leukoencephalopathy after 
Inhalation of Poisoned Heroin - MR Findings. Am. J. Neuroradiol. 1994, 15 (1), 175-
178. 
17. Wolters, E. C.; Stam, F. C.; Lousberg, R. J.; Vanwijngaarden, G. K.; Rengelink, H.; 
Schipper, M. E. I.; Verbeeten, B., Leukoencephalopathy after Inhaling Heroin 
Pyrosylate. Lancet 1982, 2 (8310), 1233-1237. 
18. Wampler, T. P., Practical Applications of Analytical Pyrolysis. J. Anal. Appl. 
Pyrolysis 2004, 71 (1), 1-12. 
19. Gayton-Ely, M. Detection and Determination of Degradation and Metabolic Products 
of Drugs of Abuse and Explosives. West Virginia University, Morgantown, 2009. 
 
 142 
20. Gayton-Ely, M.; Shakleya, D. M.; Bell, S. C., Application of a Pyroprobe to Simulate 
Smoking and Metabolic Degradation of Abused Drugs through Analytical Pyrolysis. 
J. Forensic Sci. 2007, 52 (2), 473-478. 
21. Shakleya, D. M.; Kraner, J. C.; Clay, D. J.; Callery, P. S.; Bell, S. C., Validation of a 
Headspace Gc Method for the Analysis of a Pyrolytic Product of Methamphetamine 
in Urine. J. Anal. Toxicol. 2006, 30 (8), 559-562. 
22. Shakleya, D. M.; Plumley, A. E.; Kraner, J. C.; Bell, S. C.; Callery, P. S., Trace 
Evidence of Trans-Phenyl Propene as a Marker of Smoked Methamphetamine. J. 
Anal. Toxicol. 2008, 32 (8), 705-708. 
23. Baker, R. R.; Bishop, L. J., The Pyrolysis of Tobacco Ingredients. J. Anal. Appl. 
Pyrolysis 2004, 71 (1), 223-311. 
24. Baker, R. R.; Bishop, L. J., The Pyrolysis of Non-Volatile Tobacco Ingredients Using 
a System That Simulates Cigarette Combustion Conditions. J. Anal. Appl. Pyrolysis 
2005, 74 (1-2), 145-170. 
25. Commonly Abused Prescription Drugs. National Institute of Drug Abuse: 2011 
26. Pagliaro, L. A.; Pagliaro, A. M., Pagliaro's Comprehensive Guide to Drugs and 
Substances of Abuse. 2nd Edition ed.; American Pharmacists Association: 
Washington, DC, 2009. 
27. Martin, M.; Hecker, J.; Clark, R.; Frye, J.; Jehle, D.; Lucid, E. J.; Harchelroad, F., 
China White Epidemic: An Eastern United States Emergency Department 
Experience. Ann. Emerg. Med. 1991, 20 (2), 158-164. 
28. Clarke's Analysis of Drugs and Poisons in Pharmaceuticals, Body Fluids and 
Postmortem Material. Pharmaceutical Press: London, UK, 2004. 
29. Thurlkill, R. L.; Cross, D. A.; Scholtz, J. M.; Pace, C. N., Pka of Fentanyl Varies with 
Temperature: Implications for Acid-Base Management During Extremes of Body 
Temperature. J. Cardiothorac. Vasc. Anesth. 2005, 19 (6), 759-762. 
30. Salem, H.; Ballantyne, B.; Katz, S. A., Inhalation Toxicology of Riot Control Agents. 
In Inhalation Toxicology, 2nd Edition ed.; Salem, H.; Katz, S. A., Eds. CRC Press: 
Boca Raton, FL, 2006. 
31. Smialek, J. E.; Levine, B.; Chin, L.; Wu, S. C.; Jenkins, A. J., A Fentanyl Epidemic in 
Maryland 1992. J. Forensic Sci. 1994, 39 (1), 159-164. 
32. Kuhlman, J. J., Jr.; McCaulley, R.; Valouch, T. J.; Behonick, G. S., Fentanyl Use, 
Misuse, and Abuse: A Summary of 23 Postmortem Cases. J. Anal. Toxicol. 2003, 27 
(7), 499-504. 
33. Martin, T. L.; Woodall, K. L.; McLellan, B. A., Fentanyl-Related Deaths in Ontario, 
Canada: Toxicological Findings and Circumstances of Death in 112 Cases (2002-
2004). J. Anal. Toxicol. 2006, 30 (8), 603-610. 
34. Schumann, H.; Erickson, T.; Thompson, T. M.; Zautcke, J. L.; Denton, J. S., Fentanyl 
Epidemic in Chicago, Illinois and Surrounding Cook County. Clin. Toxicol. 2008, 46 
(6), 501-506. 
35. Thompson, J. G.; Baker, A. M.; Bracey, A. H.; Seningen, J.; Kloss, J. S.; Strobl, A. 
Q.; Apple, F. S., Fentanyl Concentrations in 23 Postmortem Cases from the Hennepin 
County Medical Examiner's Office. J. Forensic Sci. 2007, 52 (4), 978-981. 
36. Control of a Chemical Precursor Used in the Illicit Manufacture of Fentanyl as a List 
I Chemical. Fed. Regist. 2007, 72 (77), 20039-20047. 
 
 143 
37. Hanks, G. W.; de Conno, F.; Cherny, N.; Hanna, M.; Kalso, E.; McQuay, H. J.; 
Mercadante, S.; Meynadier, J.; Poulain, P.; Ripamonti, C.; Radbruch, L.; Casas, J. R. 
I.; Sawe, J.; Twycross, R. G.; Ventafridda, V.; European Assoc Palliative, C., 
Morphine and Alternative Opioids in Cancer Pain: The Eapc Recommendations. Br. 
J. Cancer 2001, 84 (5), 587-593. 
38. Kress, H. G.; Boss, H.; Delvin, T.; Lahu, G.; Lophaven, S.; Marx, M.; Skorjanec, S.; 
Wagner, T., Transdermal Fentanyl Matrix Patches Matrifen (R) and Durogesic (R) 
Dtrans (R) Are Bioequivalent. Eur. J. Pharm. Biopharm. 2010, 75 (2), 225-231. 
39. Clarke's Analysis of Drugs and Poisons in Pharmaceuticals, Body Fluids and 
Postmortem Material. 3rd ed.; Pharmaceutical Press: London, UK, 2004. 
40. Arvanitis, M. L.; Satonik, R. C., Transdermal Fentanyl Abuse and Misuse. Am. J. 
Emerg. Med. 2002, 20 (Journal Article), 58-59. 
41. Marquardt, K. A.; Tharratt, R. S., Inhalation Abuse of Fentanyl Patch. Clin. Toxicol. 
1994, 33 (1), 75-78. 
42. Woodall, K. L.; Martin, T. L.; McLellan, B. A., Oral Abuse of Fentanyl Patches 
(Duragesic): Seven Case Reports. J. Forensic Sci. 2008, 53 (1), 222-225. 
43. Tharp, A. M.; Winecker, R. E.; Winston, D. C., Fatal Intravenous Fentanyl Abuse: 
Four Cases Involving Extraction of Fentanyl from Transdermal Patches. Am. J. 
Forensic Med. Pathol. 2004, 25 (2), 178-181. 
44. Arvanitis, M. L.; Satonik, R. C., Transdermal Fentanyl Abuse and Misuse. Am. J. 
Emerg. Med. 2002, 20, 58-9. 
45. Coon, T. P.; Miller, M.; Kaylor, D.; Jones-Spangle, K., Rectal Insertion of Fentanyl 
Patches: A New Route of Toxicity. Ann. Emerg. Med. 2005, 46 (5), 473. 
46. Labroo, R. B.; Paine, M. F.; Thummel, K. E.; Kharasch, E. D., Fentanyl Metabolism 
by Human Hepatic and Intestinal Cytochrome P450 3A4: Implications for 
Interindividual Variability in Disposition, Efficacy, and Drug Interactions. Drug 
Metab. Dispos. 1997, 25 (9), 1072-1080. 
47. Silverstein, J. H.; Rieders, M. F.; McMullin, M.; Schulman, S.; Zahl, K., An Analysis 
of the Duration of Fentanyl and Its Metabolites in Urine and Saliva. Anesth. Analg. 
1993, 76 (3), 618-621. 
48. Collett, B. J., Opioid Tolerance: The Clinical Perspective. Br. J. Anaesth. 1998, 81 
(1), 58-68. 
49. Kamendulis, L. M.; Brzezinski, M. R.; Pindel, E. V.; Bosron, W. F.; Dean, R. A., 
Metabolism of Cocaine and Heroin Is Catalyzed by the Same Human Liver 
Carboxylesterases. J. Pharmacol. Exp. Ther. 1996, 279 (2), 713-717. 
50. Lockridge, O.; Mottershawjackson, N.; Eckerson, H. W.; Ladu, B. N., Hydrolysis of 
Diacetylmorphine (Heroin) by Human-Serum Cholinesterase. J. Pharmacol. Exp. 
Ther. 1980, 215 (1), 1-8. 
51. Salmon, A. Y.; Goren, Z.; Avissar, Y.; Soreq, H., Human Erythrocyte but Not Brain 
Acetylcholinesterase Hydrolyses Heroin to Morphine. Clin. Exp. Pharmacol. Physiol. 
1999, 26 (8), 596-600. 
52. Moffat, A. C.; Osselton, M. D.; Widdop, B.; Watts, J., Clarke's Analysis of Drugs and 
Poisons : In Pharmaceuticals, Body Fluids and Postmortem Material. Pharmaceutical 
Press: 2011; p 2609p. 
53. Dancer, S. J.; McNair, D.; Finn, P.; Kolsto, A. B., Bacillus Cereus Cellulitis from 
Contaminated Heroin. J. Med. Microbiol. 2002, 51 (3), 278-281. 
 
 144 
54. McLachlan-Troup, N.; Taylor, G. W.; Trathen, B. C., Diamorphine Treatment for 
Opiate Dependence: Putative Markers of Concomitant Heroin Misuse. Addict. Biol. 
2001, 6 (3), 223-231. 
55. McLauchlin, J.; Mithani, V.; Bolton, F. J.; Nichols, G. L.; Bellis, M. A.; Syed, Q.; 
Thomson, R. P. M.; Ashton, J. R., An Investigation into the Microflora of Heroin. J. 
Med. Microbiol. 2002, 51 (11), 1001-1008. 
56. Moustoukas, N. M.; Nichols, R. L.; Smith, J. W.; Garey, R. E.; Egan, R. R., 
Contaminated Stree Herion - Relationship to Clinical Infections. Arch. Surg. 1983, 
118 (6), 746-749. 
57. Cook, C. E., Pyrolytic Characteristics, Pharmacokinetics, and Bioavailability of 
Smoked Heroin, Cocaine, Phencyclidine, and Methamphetamine. In National 
Institute on Drug Abuse Research Monograph Series 115: Methamphetamine Abuse: 
Epidemiologic Issues and Implications, Miller, M. A.; Kozel, N. J., Eds. National 
Institute on Drug Abuse: Rockville, MD, 1991; Vol. 115. 
58. Cook, C. E.; Brine, D. R., Pyrolysis Products of Heroin. J. Forensic Sci. 1985, 30 (1), 
251-261. 
59. Cook, C. E.; Jeffcoat, A. R., Pyrolytic Degradation of Heroin, Phencyclidine, and 
Cocaine: Identification of Products and Some Observations on Their Metaboism. In 
National Institute on Drug Abuse Research Monograph Series 99: Research Findings 
on Smoking of Abused Substances, Chiang, C. N.; Hawks, R. L., Eds. National 
Institute on Drug Abuse: Rockville, MD, 1990; Vol. 99, pp 97-120. 
60. Lichtman, A. H.; Meng, Y.; Martin, B. R., Inhalation Exposure to Volatilized Opioids 
Produces Antinociception in Mice. J. Pharmacol. Exp. Ther. 1996, 279 (1), 69-76. 
61. Huizer, H., Analytical Studies on Illicit Heroin. Pharm. Weekbl. 1989, 11 (5), 179-
180. 
62. The Mysterious Heroin Pills for Smoking. Bull. Narc. 1953, 5 (2), 49-54. 
63. Huizer, H.; Vanzuilen, K.; Svendsen, A. B., From Opium to Illicit Heroin. Pharm. 
Weekbl. 1987, 9 (4), 223-223. 
64. Klous, M. G.; Lee, W. C.; Hillebrand, M. J. X.; van den Brink, W.; van Ree, J. M.; 
Beijnen, J. H., Analysis of Diacetylmorphine, Caffeine, and Degradation Products 
after Volatilization of Pharmaceutical Heroin for Inhalation. J. Anal. Toxicol. 2006, 
30 (1), 6-13. 
65. Klous, M. G.; Nuijen, B.; van den Brink, W.; van Ree, J. M.; Beijnen, J. H., 
Development and Manufacture of Diacetylmorphine/Caffeine Sachets for Inhalation 
Via 'Chasing the Dragon' by Heroin Addicts. Drug Dev. Ind. Pharm. 2004, 30 (7), 
775-784. 
66. Huizer, H., Analytical Studies on Illicit Heroin.5. Efficicacy of Volatilization During 
Heroin Smoking. Pharm. Weekbl. 1987, 9 (4), 203-211. 
67. Friedman, L. S., Real-Time Surveillance of Illicit Drug Overdoses Using Poison 
Center Data. Clin. Toxicol. 2009, 47 (6), 573-579. 
68. Henderson, G. L., Designer Drugs: Past History and Future Prospects. J. Forensic 
Sci. 1988, 33, 569-575. 
69. Strang, J.; Griffiths, P.; Gossop, M., Heroin Smoking by 'Chasing the Dragon': 
Origins and History. Addiction 1997, 92 (6), 673-683. 
70. The Smoking of Heroin in Hong Kong. Bull. Narc. 1958,  (3), 6-7. 
 
 145 
71. Gruhzit, C. C. Pharmacological Investigation and Evaluation of the Effects of 
Combined Barbiturate and Heroin Inhalation, by Addicts Bull. Narc. [Online], 1958, 
p. 8-10. http://www.unodc.org/unodc/en/data-and-analysis/bulletin/bulletin_1958-01-
01_3_page004.html (accessed December 17, 2011). 
72. Drugs Forum. http://www.drugs-forum.com/index.php (accessed July 6, 2010). 
73. Erowid Experiences Vaults. http://www.erowid.org (accessed June 6, 2011). 
74. Bluelight. http://www.bluelight.ru/vb/ (accessed June 4, 2011). 
75. Gayton-Ely, M.; Shakleya, D. M.; Bell, S. C., Application of a Pyroprobe to Simulate 
Smoking and Metabolic Degradation of Abused Drugs through Analytical Pyrolysis. 
J Forensic Sci. 2007, 52 (2), 473-8. 
76. Nishikawa, R. K.; Bell, S. C.; Kraner, J. C.; Callery, P. S., Potential Biomarkers of 
Smoked Fentanyl Utilizing Pyrolysis Gas Chromatography-Mass Spectrometry. J. 
Anal. Toxicol. 2009, 33 (8), 418-422. 
77. Applied Pyrolysis Handbook. 2nd ed.; Taylor & Francis Group: Boca Raton, FL, 
2007; p 288. 
78. Moldoveanu, S. C., Techniques and Instrumentation in Analytical Chemistry. Elsevier 
B.V.: Amsterdam, The Netherlands, 2010; Vol. 28, p 724. 
79. Kinzie, P. A., Thermocouple Temperature Measurement. John Wiley & Sons, Inc.: 
1973. 
80. Pollock, D. D., The Theory and Properties of Thermocouple Elements, Astm Stp 492. 
Omega Press: Stamford, CT, 1971. 
81. Omega Temperature Measurement Handbook. 7th Edition ed.; Omega Engineering, 
Inc.: Stamford, CT, 2010; Vol. 2014. 
82. Quinn, T. J., Monographs in Physical Measurements. Academic Press Inc.: London, 
1983. 
83. Wampler, T. P.; Levy, E. J., Reproducibility in Pyrolysis - Recent Developments. J. 
Anal. Appl. Pyrolysis 1987, 12 (2), 75-82. 
84. CDS Analytical, I., Pyroprobe 5200 Manual. Oxford, PA. 
85. Moldoveanu, S. C., Techniques and Instrumentation in Analytical Chemistry. Elsevier 
B.V: Amsterdam, The Netherlands, 2010; Vol. 28, p 724. 
86. Uhde, E., Application of Solid Sorbents for Sampling of Volatile Organic 
Compounds in Indoor Air. In Organic Indoor Air Pollutants, Salthammer, T.; Uhde, 
E., Eds. Wiley-VCH Verlag GMbH & Co. KGaA: Weinheim, 2009. 
87. Skoog, D. A.; Holler, F. J.; Crouch, S. R., Principles of Instrumental Analysis. 6th 
ed.; Thomson Brooks/Cole: Belmont, CA, 2007. 
88. Watson, J. T.; Sparkman, O. D., Introduction to Mass Spectrometry. 4th ed.; John 
Wiley & Sons Ltd: England, 2007. 
89. Rial-Otero, R.; Galesio, M.; Capelo, J. L.; Simal-Gandara, J., A Review of Synthetic 
Polymer Characterization by Pyrolysis-Gc-Ms. Chromatographia 2009, 70 (3-4), 
339-348. 
90. Sobeih, K. L.; Baron, M.; Gonzalez-Rodriguez, J., Recent Trends and Developments 
in Pyrolysis-Gas Chromatography. J. Chromatogr. A 2008, 1186 (1-2), 51-66. 
91. Cognard, E.; Rudaz, S.; Bouchonnet, S.; Staub, C., Analysis of Cocaine and Three of 
Its Metabolites in Hair by Gas Chromatography-Mass Spectrometry Using Ion- Trap 
Detection for CI/MS/MS. J. Chromatogr. B. 2005, 826 (1-2), 17-25. 
 
 146 
92. Baker, R. R., A Review of Pyrolysis Studies to Unravel Reaction Steps in Burning 
Tobacco. J. Anal. Appl. Pyrolysis 1987, 11 (Journal Article), 555-573. 
93. Baker, R. R., Product Formation Mechanisms inside a Burning Cigarette. Prog. 
Energy Combust. Sci. 1981, 7 (2), 135-153. 
94. Baker, R. R., Temperature Distribution inside a Cigarette. Nature 1974, 247, 405-
406. 
95. Baker, R. R., Temperature Variation within a Cigarette Combustion Coal During the 
Smoking Cycle. High Temp. Sci. 1975, 7, 236-247. 
96. Baker, R. R., Combustion and Thermal-Decomposition Regions inside a Burning 
Cigarette. Combust. Flame 1977, 30 (1), 21-32. 
97. Baker, R. R., Tobacco: Production, Chemistry, and Technology. Blackwell Science: 
1999; pp 398-439. 
98. Baker, R. R., Smoke Generation inside a Burning Cigarette: Modifying Combustion 
to Develop Cigarettes That May Be Less Hazardous to Health. Prog. Energy 
Combust. Sci. 2006, 32 (4), 373-385. 
99. Baker, R. R., Variation of the Gas-Formation Regions within a Cigarette Combustion 
Coal During the Smoking Cycle. Beitr. Tabakforsch. Int. 1981, 11 (1), 1-17. 
100. Shakleya, D. M.; Tarr, S. G.; Kraner, J. C.; Clay, D. J.; Callery, P. S., Potential 
Marker for Smoked Methamphetamine Hydrochloride Based on a Gas 
Chromatography-Mass Spectrometry Quantification Method for Trans-
Phenylpropene. J. Anal. Toxicol. 2005, 29 (6), 552-5. 
101. Physician's Desk Reference. 60 ed.; Thomson PDR: Montvale, NJ, 2006. 
102. Manral, L.; Gupta, P. K.; Suryanarayana, M. V. S.; Ganesan, K.; Malhotra, R. C., 
Thermal Behaviour of Fentanyl and Its Analogues During Flash Pyrolysis. J. Therm. 
Anal. Calorim. 2009, 96 (2), 531-534. 
103. Graham Solomons, T. W.; Fryhle, C. B., Organic Chemistry. John Wiley & Sons, 
Inc.: New York, NY, 2002. 
104. Damato, R. J.; Lipman, L. P.; Snyder, S. H., Selectivity of the Parkinsonian 
Neurotoxin MpTP - Toxic Metabolite MPP+ Binds to Neuromelanin. Science 1986, 
231 (4741), 987-989. 
105. Chiba, K.; Trevor, A. J.; Castagnoli, N., Active Uptake of MPP+, a Metabolite of 
MPTP, by Brain Synaptosomes. Biochem. Biophys. Res. Commun. 1985, 128, 1229-
1232. 
106. Langston, J. W.; Irwin, I.; Langston, E. B.; Forno, L. S., 1-Methyl-4-
Phenylpyridinium Ion (MPP+) - Identification of a Metabolite of MPTP, a Toxin 
Selective to the Substantia Nigra. Neurosci. Lett. 1984, pp 87-92. 
107. Moehrle, H.; Ottersbach, D., Natriumquecksilberedetat-Dehydrierung N-Aliphatisch 
Substituierter 1,2,3,6-Tetrahydropyridin-Derivate. Arch. Pharm. 1990, 323 (2), 109-
115. 
108. Garg, A.; Solas, D. W.; Takahashi, L. H.; Cassella, J. V., Forced Degradation of 
Fentanyl: Identification and Analysis of Impurities and Degradants. J. Pharm. 
Biomed. Anal. 2010, 53 (3), 325-334. 
109. Holleyhead, R., Ignition of Flammable Gases and Liquids by Cigarettes: A Review. 
Sci. Justice 1996, 36 (4), 257-266. 
110. Bartlett, E.; Mikulis, D. J., Chasing "Chasing the Dragon" with Mri: 
Leukoencephalopathy in Drug Abuse. Br. J. Radiol. 2005, 78 (935), 997-1004. 
 
 147 
111. Baker, R. R., Temperature Variation within a Cigarette Combustion Coal During the 
Smoking Cycle. High Temp. Sci. 1975, 7, 236-247. 
112. Laszlo, T. S.; Watson Iii, F. M., A Scanning Infrared Technique for Cigarette Coal 
Peak Temperature Measurements. Beitr. Tabakforsch. Int. 1974, 269-275. 
113. Haken, J. K., Pyrolysis Gas Chromatography of Coating Materials - a Bibliography. 
Prog. Org. Coat. 1999, 36 (1-2), 1-10. 
114. Martin, K., Inert Reassessment: 2-Ehtyl-1-Hexanol; Cas#104-76-7,2006 
115. Cole, C.; Jones, L.; McVeigh, J.; Kicman, A.; Syed, Q.; Bellis, M., Adulterants in 
Illicit Drugs: A Review of Empirical Evidence. Drug Test. Anal. 2011, 3 (2), 89-96. 
116. Reuters, P.; Caulkins, J. P., Illegal "Lemons": Price Dispersion in Cocaine and Heroin 
Markets. Bull. Narc. 2004, 56 (1 and 2), 141-165. 
117. Sekine, H.; Nakahara, Y., Abuse of Smoking Methamphetamine Mixed with Tobacco 
.1. Inhalation Efficiency and Pyrolysis Products of Methamphetamine. J. Forensic 
Sci. 1987, 32 (5), 1271-1280. 
118. Sekine, H.; Nakahara, Y., Abuse of Smoking Methamphetamine Mixed with Tobacco 
.2. The Formation Mechanism of Pyrolysis Products. J. Forensic Sci. 1990, 35 (3), 
580-590. 
119. Klous, M. G.; Lee, W. C.; van den Brink, W.; van Ree, J. M.; Beijnen, J. H., 
Volatilisation of Diacetylmorphine: In Vitro Simulation of  'Chasing the Dragon'. 
Pharmazie 2006, 61 (5), 438-445. 
120. Wang, Y. S.; Hwang, K. L.; Chen, Y. L., Absorption, Translocation and Metabolism 
of the Herbicide Naproanilide in Tobacco. Pestic. Sci. 1994, 42 (1), 53-58. 
121. Snyder, R., Ethyl Browning's Toxicity and Metabolism of Industrial Solvents. 
Elsevier: Amsterdam-NewYork-Oxford, 1990; Vol. II. 
122. Propionanilide; MSDS No. S813990. Sigma-Aldrich Co. LLC: St. Louis, Missouri. 
123. Phenylacetaldehyde; MSDS No. 107395. Sigma-Aldrich Co. LLC: St. Louis, 
Missouri. 
124. 6-Acetylmorphine; MSDS No. A-003. Cerilliant: Round Rock, TX. 
125. Aniline; MSDS No. 242284. Sigma-Aldrich Co. LLC: St. Louis, Missouri. 
 
 
